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ABSTRACT
MOLECULAR STUDIES OF 




Highly specific monoclonal antibodies and 
raicrofluorimetry were used to determine the absolute number 
of B and T lymphocytes in the peripheral blood of bovine 
leukemia virus (BLV) infected cattle. The peripheral blood 
lymphocyte populations from BLV-infected cattle were
elevated when compared to BLV-negative animals. The
increase in the lymphocyte population in the aleukemic (AL) 
animals was due to an increase in T lymphocytes. In the PL
animals the increase was due mainly to an increase of B
lymphocytes but also to an increase of T lymphocytes.
The PL animals showed a significantly higher number of 
surface immunoglobulin positive cells (slg'*') than did the AL
animals. The majority of these cells contained surface IgM
and had large quantities of this marker on their cell 
surfaces. One PL animal (632) had a very high lymphocyte 
count and contained lymphocytes that appeared to stain with 
markers for both bovine B and T lymphocytes.
xvi
Bovine T lymphocytes were purified from the peripheral 
blood Df BLV~infected, AL cattle using icnmuno-affinity 
depletion technique ("panning") with anti-bovine 
immunoglobulin-coated flasks. Large yields of highly 
purified T lymphocyte preparations (95-10054 T lymphocytes 
and 0-3?. contamination with B lymphocytes) were obtained by 
the use of this technique.
The BLV provirus was found in the DNA of peripheral 
blood lymphocytes and 3 of A purified T lymphocyte 
preparations from AL animals using hybridization analysis 
uith radiolabeled BLV-DNA as a probe. Hybridization 
analysis also confirmed that the B lymphocyte is the major 
target of BLV infection.
The blastogernic response of lymphocytes from PL and AL 
animals to selected phytomitogens appeared to be normal when 
compared to the responses of BLV-negative, clinically normal 
animals. The sera from both AL and PL animals contained a 
heat-stable* camitogenic blastogenesis-augmenting factor.
xvii
CHAPTER is INTRODUCTION
Enzootic bovine leukosis (EBL) is a neoplasm of 
lymphatic tissue in the bovine species (B). The etiologic 
agent is bovine leukemia virus (BLV) (10B)* an exogenous* 
leukomogenic virus of the family Retroviridae. This virus 
may induce two clinical manifestations of disease either a 
benign proliferation of lymphocytes referred to as 
persistent lymphocytosis (PL) or the development of 
malignant lymphosarcoma (LS) (46). The majority of animals 
infected with BLV do not show any clinical signs of disease 
(88). These animals are referred to as inapparent carriers 
or as being aleukemic (AL). Some of these AL animals (25 X) 
will develop PL* and a small percentage (0.1 to 1 X) will 
develop LS (108).
Studies have been conducted to investigate the 
relationship between the PL and LS stages of EBL (46*51)* 
but* very few studies have been done to investigate the 
relationship between the AL and PL stages of EBL. This may 
be very important since the switch from the AL to PL stage 
may be one of the primary steps in the progression of the 
disease to the tumor phase. Over 75X of LS cattle have a 
chronic PL phase which precedes tumor development (108).
A target cell of BLV-infection in the cow has been 
reported to be the B lymphocyte (121). The majority of 
lymphocytes found in the peripheral blood of PL cattle have 
surface markers typical of B lymphocytes (110*156)* and a
1
percentage of these cells have been shown to exhibit viral 
antigens on their cell surfaces (72). A recent report 
suggested that some tumors consisted of cells that not only 
bear surface antigens of T lymphocyte lineage but also 
contain the BLV provirus <9D). The role of bovine T 
lymphocytes in the progression of EBL has not been 
investigated.
Reports in the current literature have focused on the 
antigenic relatedness of BLV and the human T lymphotropic 
viruses HTLV I & II. These viruses are associated with 
human T cell leukemias (116*128). The T lymphocyte appears 
to be the target of both of these viral agents. Therefore* 
if T lymphocytes are found to be target cells of BLV and/or 
important in the progression of EBL* not only will this 
information aid in the better understanding of bovine 
leukosis* it may also help to establish an animal model to 
study human viral induced leukemia.
I. A. STATEMENT OF RESEARCH PROBLEM
Bovine T Lymphocytes from AL and PL cattle are the 
subject of these studies. Definitive studies on these cells 
in EBL have not been conducted mainly because purified 
preparations and specific markers for these cells have not 
been available. Monoclonal antibodies directed toward the 
surface antigens of bovine cells of the T lymphocyte lineage 
have recently been produced and characterized (90)* but
purification techniques have not been perfected to give good 
yields of highly purified lymphocyte subpopulations. In 
order to determine whether T lymphocytes may serve as 
targets for BLV it is nessecary to have large quantities of 
purified T lymphocytes for DNA hybridization analysis.
Further studies on T lymphocytes may help to define 
how the AL to PL shift is mediated. Information on the 
absolute number of T lymphocytes in the peripheral blood of 
AL and PL cattle may indicate that there is a modulation of 
this cell population in these animals. This modulation may 
occur as a result of BLV—infection. Information on the, 
functional ability of T lymphocytes from AL and PL cattle to 
respond to selected phytomitogens may indicate a modulation 
of the functional ability of these cells (T-helper and T- 
suppressor). The uncontrolled proliferation of 
undifferientiated B lymphocytes in the PL animal may be the 
result of a lack of or enhancement of a particular T cell 
subset function. Therefore* studies on bovine T lymphocytes 
are needed to attempt to define the role if any of these 
cells in the AL and PL phases of EBL.
I. B. OBJECTIVES
The different chapters of this dissertation describe 
specific experiments that were employed to accomplish the 
following objectives!
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1, To determine the numbers of bovine T and B 
lymphocytes from AL and PL cattle using 
monoclonal antibodies that distinguish these 
lymphocytes.
2- To purify T lymphocytes from bovine peripheral 
blood mononuclear cells (PBMC) of cattle using 
immuno-affinity depletion "panning".
3. To assess the presence of BLV provirus in 
purified T lymphocytes and PBMC of AL cattle and 
the PBMC of PL cattle using DNA hybridization 
analysis.
4. To evaluate and compare the responses of 
lymphocytes in AL and PL cattle to selected 
phytomitogens using the lymphocyte 
blastogenesis assay.
The aim of these investigations is to acquire a better 
understanding of the role that bovine T lymphocytes play in 
the maintainance of the AL and PL stages of EBL. The 
results from these investigations are presented as 
individual chapters. Some of these have been submitted for 
publication to different Journals. They are entitled as 
indicated belou:
"Enumeration of T and B lymphocytes in aleukemic and 
persistent lymphocytotic cattle using monoclonal 
antibodies that distinguish these cells.
Submitted for publication to the "Journal of the 
National Cancer Institute". Co-authored by U. Davis 
and G. Amborski.
■Purification of bovine T lymphocytes from peripheral 
blood mononuclear cells using an immuno-affinity 
depletion technique ("panning"). Accepted for 
publication in "Veterinary Immunology and 
Immunopathology". Co-authored by J. Lo and
G. Amborski.
"Assessment of the presence of bovine leukemia 
provirus in the DNA of purified bovine T 
lymphocytes of BLV-infected* aleukemic cattle." 
Manuscript in preparation for publication to 
"Cancer Research". Co—authored by G. Amborski.
"Evaluation of the responses of lymphocytes of 
aleukemic and persistent lymphocytotic cattle to 
selected phytomitogens". Manuscript in preparation 
for submission to the "American Journal of 
Veterinary Research". Co-authored by 0. Barta 
and G. Amborski.
CHAPTER IIs LITERATURE REVIEW:
A - ENZOOTIC BOVINE LEUKOSIS
Enzootic bovine leukosis (EBL) is a lymphoproliferative 
disease of the bovine species (6>. The etiologic agent is 
bovine leukemia virus (BLV), an exogenous leukemogenic virus 
of the family Retroviridae (108,75). The presence of this 
virus appears to be a prerequisite for tumor development, 
but, it is not by itself sufficient to cause the disease 
(75). The virus may induce either inapparent, aleukemic 
(AL) infections or two clinical manifestations of the 
disease, persistent lymphocytosis (PL) or malignant 
lymphosarcoma (LS) (46).
II. A. 1. Aleukemic State
Once infected with BLV, cattle show no signs of overt 
viremia, however, they elicit a strong and persistent 
humoral response to BLV structural proteins (49). Most 
infected cattle <75%) have no clinical signs of disease. 
These animals are inapparent carriers or AL cattle. Weight 
gain and milk production is unaltered (88). Lymphocyte 
counts remain in the normal range between 2.5 to 7.5 x 
ID3/mm3 of whole blood (2). There has been very little 
information reported about the AL state of BLV— infection.
II. A. 2. Persistent Lymphocytotic State
Approximately 30% of BLV infected cattle develop PL 
(108). This stage of BLV— infection is a nonmalignant
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hematological disorder characterized by an increase of 
circulating peripheral blood lymphocytes (PBL) (> 7.5 x 
lO^/mm3 of whole blood) for over a period of 3 months (2). 
Weight gain and milk production appear to be unaltered (88). 
In most of the PL animals tested* it appears that the 
increase in the number of PBL is attributed to an increase 
in B lymphocytes (110*156). An increase in T lymphocytes of 
some animals has also been reported (142). The PL state is 
generally a chronic condition that may or may not lead to 
the tumor stage of EBL (108*51). The PL phase precedes the 
tumor phase (LS) in approximately 75’/, of the cases (51).
12. A. 3. Enzootic Bovine Lymphosarcoma
The adult form of bovine lymphosarcoma or EBL is most 
prevalent in dairy cattle herds and typically occurs in 
animals older than 2 years of age. It is a chronic disease* 
evolving over extended periods (1—8 years)* with tumors 
developing in only a small number of infected animals (0.1— 
1%) (108). The majority of cattle affected by EBL are those 
from 5 to 8 years of age. Tumors observed in EBL cases are 
always of lymphoid origin and may invade mammary glands* 
subcutaneous tissues* abdominal muscles* diaphragm* heart* 
respiratory tract and spinal cord (19). Tumors are 
inconsistent in location and tumGrization is usually 
asymmetrical (53*17). As tumors grow* they mechanically 
impair normal function of organs* and the ultimate stage is 
complete destruction of the original organ structure. Any 
lymph node may be affected* but the pelvic lymph nodes are
most often involved. Lymphosarcoma induced by BLV 
eventually leads to either death of the affected animal or 
condemnation of the carcass at slaughter.
U .  A. 4. Geographic Distribution of EBL
The first cases of EBL were reported in Germany in 1B7B 
and in the United States in 1897 (9,8). The disease now has 
world wide distribution (19). In some parts of the world 
such as Switzerland and other parts of Europe, eradication 
programs are in progress (19). In these areas the number of 
cases of EBL is steadily decreasing. Some sections of the 
United States are endemic areas for EBL. One such area is 
Louisiana where many herds contain 75-100% BLV positive 
reactors (71).
II. A. 5. Diagnosis of BLV Infection
The viral etiology of EBL was shown in 1969 (106). 
Serological identification of reactors became possible in 
1972 (45). Diagnostic techniques presently available for 
the detection of BLV reactors are virus neutralization (61), 
complement fixation (140,31), agar gel immunodiffusion 
(AGID) (33,34), enzyme-linked immunoabsorbent assay (ELISA) 
(80), radioimmunoassay (RIA) (125,89), and the syncytia 
induction and syncytia induction neutralization assays using 
bovine fetal spleen cells as indicator cells (40,62). The 
AGID is the most commonly used diagnostic tool. This assay 
detects antibodies to the major envelope and core proteins 
of BLV in the serum of infected cattle. Various serologic 
diagnostic tests have demonstrated that BLV antibodies are
detectable in > 90’A of LS and PL animals (19).
II. A. 6. Transmission of BLV
Studies conducted in mant) laboratories indicate that 
contact transmission is the principal method by which BLV is 
spread (122*AS). Since BLV particles are seldom produced in 
vivo (42,3), it is likely that in most cases BLV infection 
in cattle is the result of the transfer of infected 
lymphocytes rather than viral particles. The transfer of as 
few as 1 x ID4* blood lymphocytes from infected to non— 
infected animals results in virus transmission (20). 
Penetration of the skin appears tc be the mode of entry of 
the virus, therefore* infection can be easily spread through 
multiple use of needles* ear tagging devices* dehorning and 
castration equipment (154*160). Transmission studies using 
potential insect and tick vectors have been conducted 
(21*114*130). These investigations indicate that BLV may be 
spread by stable flies (Stomoxys calcitrans)* horn flies 
(Haematobia irritans)* horse flies (Tabanidae) (21*114)* and 
some species of ticks (Boophilus microplus) (130).
Another possible means of BLV spread is in utero 
transmission. The incidence of transmission of BLV from 
infected dam to fetus is very low (46* 123). Usually less 
than 155i of BLV-infected cows give birth to infected calves 
(123). Colostrum and milk are potential sources of 
infection (50*119). Both contain BLV-infected lymphocytes* 
but the amount is minimal when compared to tnat of the blood
(109). Usually antibody present in the colostrum of
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infected cows is adequate for protecting calves until about 
a months of age <50, 49). Pasteurization of infected milk 
totally destroys BLV (5).
Vertical transmission xn the gametes has never been 
observed (109). In Sweden* transmission of BLV has occurred 
through the use of a BLV—contaminated babesiosis vaccine 
<19). All the above observations confirm that natural 
spread of BLV occurs mainly through the horizontal route.
II. B. BLV Infection in Other Animal Species
Natural cases of viral-induced lymphomas in sheep are 
rare. The virus isolated from these cases appear 
indistinguishable from BLV (19). Sheep have been 
experimentally infected with either cell—free virus or BLV- 
infected lymphocytes from infected cattle. Typical PL does 
not occur in sheep. Lymphosarcoma usually occurs quite 
rapidly after infection (1-3 years) and at a much higher 
frequency than in cattle (19). Anatomopathological lesions 
are comparable for tumors of sheep and cattle. BLV 
sequences are present in tumor tissue but absent from normal 
tissue. Recent evidence seems to indicate that, unlike BLV- 
induced tumor cells in cattle, tumor cells in sheep are of T 
lymphocyte origin (67). BLV-infected sheep have antibodies 
to structural proteins of the virus. No viremia has ever 
been demonstrated in sheep (19). BLV-induced lymphosarcoma 
of sheep does not seem to be naturally transmitted from
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animal to animal.
BLV-induced lymphosarcoma has been demonstrated in only 
one other animals species. After numerous attempts to 
induce LS in goats with BLV experimentally* one case was 
reported (115). Lymphoid tumors appeared in many organs 6 
years postinfection. Many other animal species such as 
chimpanzees* pigs* domestic rabbits* cats, dogs, deer, rats* 
and guinea pigs have been experimentally infected with BLV* 
but in none of these species were viremia or pathological 
disorder observed (97*153). The only species which 'remained 
antibody positive was the chimpanzee (153). BLV infection 
in humans has never been documented (6*153*97).
II. C. SPORADIC BOVINE LEUKOSIS
EBL induced by BLV should be distinguished from 
sporadic bovine leukosis (SBL) which includes the Juvenile* 
skin* and thymic forms of the disease (1). Only EBL is 
associated with BLV infection. The SBL forms occur at 
random* having no proven association with an infectious 
etiology. The possibility exists that other bovine 
retroviruses may be associated with this condition* although 
this has not been thoroughly investigated. A transient 
lymphocytosis may be detected in some SBL cases. The target 
cell of SBL appears to be the lymphocyte stem cell because 
tumors consist of cells of both T and B lymphocytes lineage 
(19). The calf or Juvenile form generally occurs in calves
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less than 6 months of age* however* it can occur in older 
animals. Tumor cells can be found in lymph nodes* liver* 
spleen and bone marrow. In contrast the thymic form, 
typically restricted to the region of the thymus* the calf 
form typically occurs in young animals (6 to 3D months of 
age) and appears mainly in beef herds rather than in dairy 
herds (43). The skin form is extremely rare* and the only 
form of lymphosarcoma that is not fatal. Lesions of this 
form may regress but a generalized lymphadenopathy may occur 
(19).
II. D. OTHER BOVINE LYMPHOTROPHIC RETROVIRUSES
Studies on EBL have resulted in the isolation of two 
other bovine retroviruses* bovine syncytial virus (BSV) and 
bovine visna-like virus (BVV) which also produce syncytia in 
cell culture (54*96). Their relationship to EBL is unclear. 
However, neither agent is considered to be a significant 
factor in the cause of EBL (149*150).
II. D. 1. Bovine Syncytial Virus
BSV is a bovine lymphotrophic retrovirus that was 
originally isolated from buffy coat cells* spleen* lymph 
nodes and milk of lymphosarcomatous and normal cattle (150). 
The target cell(s) of this virus is not known nor is the 
effect of infection on susceptible animals. This viral agent 
induces syncytia formation in monolayer cultures of bovine 
fetal spleen cells and has been morphologically
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characterized as a foamy virus (96*150). BSV was 
originally suspected of being the etiologic agent of EBL 
(96). Subsequent studies demonstrated that only 22% of LS 
animals had detectable levels of serum antibodies to BSV* 
whereas* over 90% of LS animals had detectable antibodies to 
BLV (148,19). Observations of experimentally infected 
calves and immunodiffusion tests of sera from normal and 
lymphosarcomatous cattle as well as cattle from multiple 
incidence lymphosarcoma herds have not provided evidence for 
a direct etiologic involvement of BSV in either the PL or LS 
stages of EBL (148).
II. D. 2 Bovine Visna—Like Virus
A syncytia-inducing virus (BVV) isolated from a cow
with PL was found to be similar in structure to maedi, 
visna, and progressive pneumonia viruses of sheep (149). 
Calves inoculated with virus isolated from this PL cow 
developed a mild nonpersistent lymphocytosis and 
subcutaneous lymphatic nodules. The relationship of BVV to 
the induction of PL is unclear, but it does not appear that 
this viral agent is a significant factor in the development 
of PL or LS (149).
II. E. LYMPHOCYTES IN ENZOOTIC BOVINE LEUKOSIS
Lymphocytes in man and animals are composed of two 
subpopulations: thymus—derived (T) lymphocytes, which are 
involved in cell—mediated immunity and bursal—equivalent (B)
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lymphocytes* primarily involved in humoral immunity. An 
understanding of the recognition and effector functions of 
these lymphocytes in disease processes is clearly dependent 
on the ability to enumerate and separate these cells for 
functional analysis. Various techniques have been used for 
the isolation and enumeration of T and B lymphocytes in the 
bovine species and have been applied to BLV— infected 
animals.
11. E. 1 Lymphocyte Isolation Procedures
Bovine peripheral blood mononuclear cells (PBMC) have 
been isolated routinely using a density gradient of ficoll 
(146). This technique gives highly purified populations of 
mononuclear cells with an average of 2% polymorphonuclear 
leukocytes. Numerous other techniques have been utilized to 
isolate lymphocyte subpopulations. Nylon wool columns have 
been used to fractionate B and T lymphocytes (121) and yield 
highly purified T (nonadherent) and B (adherent) lymphocyte 
populations (95%)* but recoveries are very low (2 to 20%). 
Antibody—complement immunolysis has been used to selectively 
deplete B lymphocytes from PBMC and hence enrichs the T 
lymphocyte population (146). This technique also gives low 
yields of purified T lymphocytes. Bovine serum albumin 
gradients have been used to isolate subpopulations of bovine 
lymphocytes on the basis of their bouyant density. The 
purity and yield of these preparations are also low (73).
The techniques currently used to isolate bovine 
lymphocyte subpopulations do not give large quantities of
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highly purified T or B lymphocytes. Recently, an immuno- 
affinity depletion technique using immunoglobulin-coated 
surfaces has been used to isolate and purify murine 
peripheral blood T and B lymphocytes (92, 95). This 
technique has not been applied to purification of large 
quantities of bovine lymphocyte subpopulations.
II. E. 2. B Lymphocyte Markers
The B lymphocytes have 3 generally recognized cell 
surface receptors: (1) surface membrane immunoglobulin (slg)
(37.36), (2) receptor for the Fc portion of immunoglobulin
(38.36) and (3) the receptor for complement (29). These 
markers have been used to distinguish bovine B lymphocytes.
The slg—bearing lymphocytes (slg'*') have been detected 
by an immunofluorescence antibody technique which uses 
fluorescein—conjugated F(ab')2 fragments of rabbit anti- 
bovine IgG (heavy and light chain specific) (Rablg—FITC) and 
recently, monoclonal anti— IgM (127,110,90). Rablg-FITC is 
specific for cells which contain slg (IgA, IgM, IgG) on 
their surface since this marker is directed against the 
neavy chains of all the immunoglobulin classes. The anti— 
IgM is specific for cells which contain surface IgM because 
this antibody is directed towards the heavy chain of IgM (u 
chain). Isotype specific lymphocyte surface immunoglobulins 
have not been as well studied in the cow as in certain other 
species. The isotypes on slg* bovine peripheral blood 
lymphocytes appear to be mainly IgM and IgA (85, 55). It 
was found that anti—bovine IgM is a highly specific marker
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for bovine peripheral blood B lymphocytes <55* 90).
Detection of the Fc receptor on the surface of bovine B 
lymphocytes has been accomplished using an 
immunofluorescence technique* erythrocyte—antibody 
complement rosetting (EAC rosette) technique and slg 
staining (B5,142*110*156). The complement receptor has also 
been used to detect B lymphocytes (10). The use of these 
techniques has led to a wide range of values for bovine B 
lymphocytes in the PBMC of normal cattle. Many of these 
techniques are very cumbersome to perform.
II. E. 3. Bovine T Lymphocyte Markers
Markers which have been used for enumeration of bovine 
T lymphocytes include: (1) receptors for sheep red blood 
cells (sRBC) (127*142)* (2) receptors for peanut agglutinin 
(PNAR) (147)* (3) alpha-naphthy1 acetate esterase (ANAE) 
positive granules (71)* and (4) T lymphocyte surface 
antigens (B4).
The frequency of lymphocytes which contain receptors 
for sRBC has been measured by the use of a sheep erythrocyte 
rosetting technique (E-rosette) (73*127*142). Peanut 
agglutinin receptor—positive cells (PNAR*) have been 
detected by a direct fluorescence technique using 
fluorescein-conjugated peanut agglutinin. This technique 
has been reported to be a very specific means of enumerating 
□ovine T lymphocytes (147* 55). Recently* with the use of 
monoclonal antibodies (MAb) directed towards T lymphocyte 
surface markers* it was found that PNAR can be found not
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anly on T lymphocytes but also on other leukocytes (90).
ANAE staining has been used as a cytochemical marker to 
enumerate bovine T lymphocytes (71), and the frequency of 
bovine T lymphocytes has been measured by direct 
immunofluorescence using anti—bovine T lymphocyte serum 
(ATS) (04).
Many of the above markers and detection techniques have 
been used to enumerate T and B lymphocytes in normal and 
BLV-infected animals. The use of the above markers for 
enumeration of bovine T lymphocytes has led to great 
variation in the numbers of these cells in the PBMC of 
normal as well as BLV-infected animals. Recently, MAb 
specific for the sRBC receptor on the surface of bovine T 
lymphocytes have been prepared, characterized and used to 
enumerate the frequency of T lymphocytes in the PBMC of 
normal cattle (90).
II. E. 4. Frequency of T and B Lymphocytes in Enzootic 
Bovine Leukosis
Some of the above techniques for B and T lymphocyte 
enumeration have been used to study the frequency of these 
cells in PBMC from cattle with AL, PL and LS. Very little 
information is available on the lymphocytes of AL animals. 
One study of 8 cattle in the AL stage showed that lymphocyte 
counts averaged between 3.4 x lO3 to 7.5 x 103/mm3of whole 
blood and between 12 to 50% of these cells were slg'*' (72).
An increase in slg^ lymphocytes in the PL phase of the 
disease has been observed (110, 85, 72). The values
averaged 2B% for BLV-negative <normal) and 63% far PL cattle
(110). One report indicated that PL cows had 3.85 times 
more slg*lymphocytes than did normal cows (85). When EAC 
rosetting was used to enumerate the frequency of £ 
lymphocytes in the PBMC of PL animals* values of 10% to 20% 
for normal cattle* and 55% to 81% for PL animals were 
observed (72). Lymphocyte counts in the PL group ranged 
from 11.0 x 103 to 22 x ID3/mm73 of whole blood* and there 
was a significant strong correlation between the percentages 
of cells bearing the B lymphocyte markers and the absolute 
lymphocyte counts (72).
Tumor development correlates with a drastic 
modification of lymphocytosis (rapid increase or decrease of 
the total lymphocyte count) and the presence in the 
peripheral blood of lymphoblasts and lymphocytes with 
altered morphological and karyotypic characteriseics (104). 
Many animals with LS have lower percentages of circulating 
slg + cells and lymphoid cells from tumorous lymph nodes of 
these animals have a higher percentage of slg bearing cells 
than normal lymph nodes (142).
Studies using E-rosette formation as a marker for 
bovine T lymphocytes indicated that between 12.5 to 26% of 
PBMC of normal cattle* 3.5 to 26.5% of PBL from BLV-infected 
cattle (AL or PL status unknown) and 0.5 to 50% of PBL from 
LS animals formed E-rosettes (142). This study also 
reported that in tho lymph nodes of BLV-negative animals*
8.5 to 30.5% of lymphoid cells formed E—rosettes. E—rosette
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positive cells from lymph nodes of BLV-infected animals 
ranged from 7 to 43.5%. Lymph node cells from LS animals 
had 10% or fewer positive cells (142). Investigations using 
(ANAE) staining to identify T lymphocytes in cattle 
concluded that an average of 47.7% ANAE positive cells were 
present in the PBMC of normal cattle* and 20.5% were 
present in the PBMC of PL cattle (71). Therefore, this study
concluded that in the PBMC of PL there was a decrease in the
number of T lymphocytes.
Studies were conducted using an indirect 
immunofluorescent antibody technique with rabbit anti—bovine 
thymocyte serum (ATS) to detect T lymphocytes in the PBMC of 
BLV-negative, PL and LS cattle and tumor cells of LS cattle
(84). The frequency of T lymphocytes in the PBMC of BLV- 
negative animals ranged from 55 to 80%, PL animals from 4 
to 45%, and LS animals from 5 to 38%. The percentage of T
cells found in tumors ranged from 2 to 30%.
As described above, the use of such a variety of 
techniques for T and B lymphocyte enumeration has led to a 
wide range of values for these cells in both normal and BLV- 
infected cattle. The MAbs recognizing bovine T lymphocytes 
have not yet been used to assess the absolute numbers of T 
lymphocytes in BLV-infected cattle.
II. E. 5. BLV Target Cells
Since tumors present in EBL are neoplasms of the 
lymphoid system, cells of the lymphocyte lineage were the 
first candidates to be suspected as BLV-preferred targets.
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This bias shown to be correct by demonstration of BLV 
production in vitro from cultures of lymphocytes from BLV- 
infected cattle (10B* 120). The target cell of BLV 
infection has been reported to be the B lymphocyte as 
evidenced by the presence of slg on the majority of tumor 
cells and BLV-infected lymphocytes in the peripheral blood 
of PL and LS cattle (72* 120). However* a recent report 
which investigated the phenotype of lymphoblastoid cell 
lines derived from two cases of LS indicates that BLV may 
also infect cells of the T lymphocyte lineage (91).
It appears that BLV is present in a subpopulation of B 
lymphocytes of PL cattle (73). A nylon wool separation 
procedure was used to fractionate the B and non—B 
populations of peripheral blood of BLV-infected cattle. It 
was discovered that the capacity to produce C-type particles 
resided with the B lymphocytes (119). This was demonstrated 
by the use of transmission electron microscopy and the 
induction of syncytia in bovine fetal spleen cells 
(120*121*73). From these studies* it was concluded that 397. 
of the B lymphocytes produced BLV particles. This implies 
that BLV may be associated with a certain subpopulation of B 
lymphocytes.
Isolation of a subpopulation of BLV-infected 
lymphocytes from AL and PL animals was accomplished by the 
use of density gradients of bovine serum albumin (B5A) (73). 
The B lymphocytes were reportedly separated into two 
distinct subpopulations* one which produced BLV and the
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second which did not produce BLV* but underwent spontaneous 
blastogenesis when cultured in vitro <73). The BLV- 
nonproducer accounts for most of the cell—count increase in 
PL as assayed by the uptake of tritiated thymidine which 
measures DNA synthesis. It is not known if the lymphocytes 
which incorporate '~*H thymidine* but do not produce BLV* 
contain the BLV provirus in a repressed state. No further 
characterization of either of these two cell populations has 
been reported.
II. E. 6. Immune Responses to BLV Infection
Humoral response to BLV antiyens has been observed 
shortly after infection (49). The presence of antibodies 
directed against the major glycoprotein of the viral 
envelope (gp51) and internal viral core protein <p24) is 
detectable shortly after experimental BLV infection (49).
The anti—gp51 antibodies are consistently formed at a higher 
titer than anti—p24 antibodies and display virus 
neutralizing activity and a strong cytolytic effect on BLV— 
producing cells in the presence of rabbit complement (47).
Recently* a study was conducted to assess the humoral 
and cellular responses in calves experimentally infected 
with BLV (107). The results showed that there was an 
increase in the number of B lymphocytes* a decrease in the 
number of T lymphocytes and reduced levels of IgM in the 
sera of BLV infected calves. These findings seemed to 
indicate that the immune system of these calves was affected 
by the viral infection and a state of immune—suppression was
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induced (107).
Responses of lymphocytes from normal) AL* PL and LS 
cattle to phytomitogens have been evaluated using the 
lymphocyte blastogenesis assay (111* 112* 157* 132). This 
assay has been used to determine the functional ability of 
both T and B lymphocytes to respond to mitogenic stimuli.
The T lymphocytes of normal cattle were found to be 
stimulated with both phytohemagglutinin (PHA) (111) 132) and 
Concanavalin A (ConA) (157). The T and B lymphocyte 
populations responded to pokeweed mitogen (PWM) (111)132). 
The mitogenic activity of PHA and PWM was studied on the 
PBMC from cows with PL, and it was found that when using 
stimulation indices) the degree of stimulation was markedly 
less for PBMC of PL cattle than for normal cows. Lymphocytes 
from cows with PL cultured without phytomitogens 
incorporated 5 times more tridiated thymidine than did 
lymphocytes from normal cows (112). It has been reported 
that this spontaneous blastogenesis is BLV—antigen driven 
because it can be inhibited by serum containing BLV 
antibodies but not by normal serum (143).
The response of cultured PBMC from cattle affected with 
EBL to the mitogenic activity of ConA has been determined 
(157). It was found that the stimulatory effect of ConA was 
significantly decreased in lymphocytes from LS cattle in} 
comparison to lymphocytes from normal animals.
The sera from cows with LS have been shown to inhibit 
the blastogenesis of normal lymphocytes (6B). This
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suppressive activity was not observed in sera from animals 
that were infected with BLV but did not have LS. These 
results indicated that sera from l.S animals contained 
suppressive factor(s). No further characterization of this 
serum factor(s) was reported.
The above studies indicated that the functional ability 
of T lymphocytes from AL animals to proliferate in response 
to mitogens appeared to be intact* but the functional 
ability of T lymphocytes in the PL and LS stages of EBL 
appeared to be suppressed. It is known that the percentage 
of T lymphocytes in the peripheral blood is significantly 
decreased in the PL animal. Therefore* the reported 
reduction in the response of the T cells in these animals 
may be due at least in part to the low number of these cells 
present in the lymphocyte blastogenesis assays.
Suppression of natural cytotoxic activity of 
lymphocytes from PL and LS animals has been observed (164). 
It was demonstrated that the cytotoxic activity of PBMC was 
closely related to the stage of the disease. The activity 
of PBMC from cattle with PL and LS was decreased markedly 
when compared to that of normal or AL animals (164).
II. F. MOLECULAR STUDIES OF BLV
IX. F. 1. Bovine Leukemia Virus
The putative etiological agent of EBL is BLV. This 
virus has been identified as an RNA virus of the family
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Retroviridae and is characterized as a C-type oncornavirus 
(158,75). Since the original discovery of BLV in the 
supernatant fluids of short—tern* cultures of PL lymphocytes* 
long-term cultures producing BLV have been obtained. These 
include cell lines derived from explanted tumor tissues or 
various epithelioid and fibroblastoid cell lines infected 
with BLV after co-cultivation with BLV-infected bovine 
lymphoid cells (151*98*44). Most of the information on the 
structure and biosynthesis of BLV components has been 
obtained from the fetal lamb kidney-BLV-producing cell line 
(FLK-BLV) (152).
The BLV virus has a sedimentation coefficient of 600S to 
70QS with a buoyant density of 1.15 to 1.18 g/ml in sucrose 
and 1.12 g/ml in metrizamide solutions (39*59*74*75). The 
diameter of mature BLV particles ranges between 68 and 125 
nm (22*23*15B). Particles contain a central electron—dense 
nucleoid with a diameter of 40 to 90 nm* and it appears that 
the nucleocapsid is icosahedral (155). The virion contains 
a 70S RNA. Denaturation of this virion RNA yields poly <A>- 
containing subunits that sediment at 38S and are found to be 
of molecular weight 2.95 x 10** daltons (ca.8.8 kb) in sodium 
dodecyl sulfate polyacrylamide gels (57*25).
II. F. 2. BLV Proteins.
The internal structural protein* p2* was the first 
recognized BLV protein. It has been purified and 
extensively characterized (58*106*32). This protein has 
been partially sequenced and appears to share the
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aminoterminal praline and carboxyterminal leucine of the p30 
of all mammalian retroviruses. However* it has been found 
that BLV p24 is antigenically distinct from the major core 
protein of most other retroviruses. Nucleic acid and amino 
acid sequence homology has been found between BLV p24 and 
the major p£4 core protein of HTLV I (118*128).
The major phosphoprotein of BLV* pl5* is a slightly 
basic protein that exists in two populations of molecules 
(70). One is linked to the lipid bilayer of the viral 
membrane* and the other is linked to viral RNA. Another 
basic protein of BLV is pi2. This protein has been shown to 
be in close proximity to viral RNA in BLV particles (144).
Zt has been reported that there is amino acid homology 
between BLV pl2 and human T—cell Leukemia virus (HTLV I) pl2 
(118*128). The other basic protein plO is able to bind to 
single-stranded DNA (93) -
Nature BLV particles also contain a RNA-dependent DNA- 
polymerase (reverse transcriptase) of an approximate 
molecular weight of 70*000 dal tons (41). This enzyme is 
strictly dependent on RNA and all four deoxyribonucleoside 
triphosphates and* irrespective of template-primer used* 
displays a strong preference for Hg’*"*" over Mn*'*' (59*58*75).
The major envelope glycoproteins of BLV are gp51 (or 
gp60) and gp3D. These proteins are found associated as a 
1*1 complex linked by disulfide bonds in viral particles 
isolated under nonreducing conditions (18). It appears that 
these proteins are both derived from a precursor protein
gPr72"‘r"’' and appear as a tetramer with two g p ^  molecules 
buried in the membrane structure of the virus* while the two 
gp51 molecules protrude outside (56*99). The overall 
structure resembles that of an inununoglobulin molecule. The 
gt*51 appears to function in the attachment of the virus to 
the target cell. Monoclonal antibodies to BLV gp51 have 
been obtained in the mouse using either nondisrupted BLV 
particles or purified gp51 as immunogens (16,15). Antigenic 
determinants on gp51 were shown to be involved in 
determining both virus infectivity of and syncytia formation 
by BLV—producing cells as well as functioning as a target 
for antibody-mediated complement-dependent cytotoxicity 
(15). It appears that the carbohydrate residues on gp51 are 
very important virus neutralization epitopes (15).
From recent reports* it appears that the BLV genome 
like that of the HTLV's (HTLV I,HTLV II, and HTLV III) may 
produce another as yet uncharacterized protein referred to 
as a trans—acting protein (tat) (138*137,131). It has been 
proposed that this protein is coded for by the long open 
reading frame (LOR) region of approximately 16DD nucleotides 
3' to the envelope gene. In HTLV I, it has been proposed 
that the HTLV tat protein mediates transcriptional trans 
activation of the HTLV long terminal repeat (LTR) (138*137). 
The transcriptional initiation signals for these 
retroviruses lie within the LTR sequences which flank the 
integrated provirus (137). A 2—kilobase message capable of 
encoding such a protein has been detected in BLV-infected
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celIs* but the protein has not been found as an in vitro 
translation product of the viral genome (131).
II. F. 3. BLV Genome.
The genome contains the coding capacity for at least 
four internal structural proteins (p24* pl5, pl2* plO>, 
reverse transcriptase (p70)* and two envelope glycoproteins 
<gp51 and gp30> (99*100). It appears that the BLV gene 
order (5' —gag-pol—env—3') is similar to that of other 
replication-competent lymphoid leukemia viruses (56). It is 
not clear whether other proteins are encoded by the viral 
genome.
Recent studies seem to indicate that the BLV genome 
contains ah additional coding region or LOR 3' to the 
envelope gene (131). This gene may code for a tat protein 
which may play a vital role in the ability of the virus to 
induce transformation (131).
Nucleic acid hybridization experiments run with single­
stranded BLV tP-cDNA have shown no homology between BLV and 
any other retrovirus with the exception of HTLV I and II 
(24*74,75*11B»12B). Significant homology has been found 
with HTLV I (118*128). Up to 45 7. nucleic acid homology 
exists between DNA coding for p24 internal core proteins of 
BLV and HTLV I (113).
II. F. 4. Morphogenesis.
Detailed investigations in various laboratories have 
led to the conclusion that BLV has distinct morphogenesis 
events from most other retroviruses (22*23). Some
investigators have shown peculiarities in budding of BLV 
viruses when comparing the budding processes of murine and 
feline oncornaviruses to that of BLV <2B). In short-term 
lymphocyte cultures* packages of virus particles accumulate 
in cytoplasmic bags surrounded by plasma membrane. BLV 
particles are rarely observed to be released from the plasma 
membrane into the pericellular spaces or into cytoplasmic 
vacuoles (151). It was suggested that virus particles do not 
mature at the cell surface but leave the cell by unusual 
routes (22*23). This mechanism of virion maturation may be 
responsible for the persistent infections observed with BLV. 
Since viral antigens may not be present in large quantities 
on the infected cell surfaces* BLV-infected cells may be 
protected from lysis mediated by antibody—dependent 
cytolysis mechanisms.
II. F. 5. Viral Persistence
The presence of antibodies directed against the major 
glycoprotein of the viral envelope (gp51) and internal viral 
core protein (p24) is detectable shortly after experimental 
BLV infection (49). The gp51 antibodies are consistently 
formed at a higher titer than p24 antibodies and display 
virus neutralizing activity and a strong cytolytic effect on 
BLV—producing cells in the presence of rabbit complement 
(47). Antigens do not appear to be expressed at detectable 
levels on infected cell surfaces in vivo. Consequently* 
production of virus in the blood plasma appears to be 
prevented. It is not known where virus replication and or
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viral antigen production actually takes place in infected 
animals.
The BLV provirus can be demonstrated in the genome of 
peripheral blood mononuclear cells (PBMC) and tumor cells 
but not nonlymphoid tissues by Southern blot hybridization 
analysis of the DNA of these cells (22,73). There appears 
to be host modulation of BLV antigen expression and 
efficient control of virus spread. The BLV proviral genome 
can be activated by mitogens (108) or short—term cultivation 
(48-72 hours) (120). Viral antigens can then be 
demonstrated on the surface of infected cells by fluorescent 
microscopy techniques (140), and mature virions can be 
detected in the .pericellular spaces by transmission electron 
microscopy (120).
The control of BLV antigen expression appears to be at 
the level of transcription (77). BLV mRNA transcripts 
cannot be detected in noncultivated circulating lymphocytes 
or tumor cells from PL or LS animals using solution 
hybridization techniques (77,76). Viral mRNA transcripts 
can be detected in these cells using highly sensitive in 
situ hybridization techniques. The amount of viral mRNA 
increases with short—term cultivation of these cells (77). 
Therefore, there appears to be control of BLV antigen 
expression. This lack of expression of gp51 on the BLV- 
infected cell surface could clearly prevent cell lysis by 
antibody mediated cytolytic mechanisms and allow for the 
expansion of BLV-carrying cells.
The mechanism by which the BLV provirus is 
transcriptionally repressed in the lymphocytes of PL and AL 
animals is not understood. A plasma protein has been 
reported to be responsible for this repression (63). This 
protein has an approximate molecular weight of 150*000 
daltons. It does not appear to be immunoglobulin or 
interferon* but a unique protein contained in the plasma 
fraction of BLV—infected bovine blood. When cel Is are 
separated from whole blood using density gradient 
centrifugation and washed* this protein is diluted or 
completely removed from the cell preparation as assessed by 
the increase of BLV p24 production using competitive 
radioimmunoassay on cell culture supernatant fluids. 
Transcription of the BLV genome can then proceed.
II. E. 6. Molecular Aspects of BLV—induced 
Leu kemogenes i s 
The exogenous nature of the BLV genome to the DNA of 
bovine cells as well as to the DNA of several other 
vertebrate species has been well documented (75*30). It has 
also been established that the BLV genetic information 
includes no one genes (80). Liquid hybridization and 
Southern blot analysis using a molecularly cloned BLV 
proviral—specific probe show that most of the cells of all 
BLV—induced tumors contain proviral genetic information 
(78). In individual tumors the site of proviral integration 
appears to be mono- or oligoclonal (78). However* no 
preferential integration site for BLV provirus* such as* in
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close proximity to a cellular one gene sequence has ever 
been demonstrated either in tumor cells or PBL of AL or PL 
cattle (60*79). Proviral insertion sites in the 
lymphocytes of AL and PL cattle have been observed to be 
polyclonal. The BLV-infected lymphocytes of animals in PL 
do not display abnormalities in their chromosomal ploidy as 
do tumor lymphocytes (66).
There appears to be a multi-step process for tumor 
development. The presence of the BLV provirus appears to be 
necessary but* by itself* insufficient to cause tumors (75). 
The role of BLV proviral information in the development 
and/or maintenance of the tumor state has been evaluated 
(78*76). Cells of BLV—induced tumors contain at least one or 
a portion of one provirus. When deletions occur, they seem 
to affect only the 5' half* as the 3' proviral sequences 
seem to be conserved. The conservation of the 3' proviral 
sequences may be of functional importance at a particular 
stage of disease development. The tat gene appears to be 
located in this portion of the genome (131). Experiments 
indicate that maintenance of the tumor state does not 
require a continuous expression of BLV proviral DNA (79). 
This may suggest that proviral transcription is important in 
a specific stage of EBL. Possibly* the PL stage of EBL is a 
manifestation of proviral gene expression. Gene product(s) 
such as the tat protein may induce rapid proliteration of 
lymphocytes. Tumor development may then be a consequence of 
chromosomal rearrangements which occur when cells
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proliferate uncontrollably. This is one mechanism 
hypothesized in the tumorgenesis of Burkett's lymphoma (35). 
However* restriction enzyme analysis of a panel of ten tumor 
DNAs has failed to demonstrate rearrangements of the 
cellular homologues of several retroviral one genes 
including c-myc, c-myb, c-erbA, c-erbB, c-abl. c-src, c- 
rasH» c-fes* and c-sis (BO). Furthermore, the DNA of most 
BLV induced tumors do not induce foci of transformed cells 
when transfected into. NIH 3T3 cells.
II. F. 7. Relatedness to Human Lymphotrophic Retroviruses 
The importance of studying the parameters involved in 
the development of EBL has been emphasized by the close 
genetic and antigenic relationship of BLV to some of the 
members of the human T lymphotrophic virus family (HTLV) 
(128,74,27). This virus family consists of three 
retroviruses, HTLV I, II and III (162). BLV is the closest 
known relative of HTLV I and II (94,128,27,133,). HTLV-I is 
the etiologic agent of adult T-cell leukemia (ATL) and HTLV- 
II has been isolated from one patient with hairy T-cell 
leukemia (129,162). Both viruses appear to induce chronic 
leukemias and malignant lymphomas in man (165). These 
viruses have a tropism for the helper T lymphocytes 
possessing the cell—surface antigen 0KT4 and have the 
capacity to transform these cells and like BLV, induce 
syncytia formation in vitro (162,68). HTLV I, II and BLV 
appear to have a similar mechanism of transcriptional 
activation and may have similar mechanisms of neoplastic
33
transformation (137,138,135,131).
A better understanding of the parameters involved in 
the development of BLV—induced lymphosarcoma may aid in the 
understanding of the mechanismts) of leukemogenesis and 
lymphomagenesis with the HTLV viruses.
CHAPTER III: ENUMERATION OF T AND B LYMPHOCYTES IN
ALEUKEMIC AND PERSISTENT LYMPHOCYTOTIC CATTLE USING 
MONOCLONAL ANTIBODIES THAT DISTINGUISH THESE CELLS.
HI. A. INTRODUCTION
Limited information has been obtained on the immune 
response of cattle to bovine leukemia virus (BLV) infection 
and the sequence of cellular events that leads to 
lymphocytosis and the development of lymphosarcoma. In 
animals which develop a persistent lymphocytosis (PL)* there 
appears to be a loss of control of B lymphocyte 
proliferation (72*84). The reason for this lack of control 
is unclear. It may be mediated* at least in parti by a 
decrease or increase in T lymphocyte numbers and* possibly* 
alteration of the function of these cells. Since T 
lymphocytes help control B lymphocyte proliteration and 
differentiation* any alteration in the T lymphocyte 
population may have profound effects on the B lymphocyte 
population (142). In a recent report* evidence was 
presented which demonstrated that calves experimentally 
infected with BLV had an increase in the B lymphocyte 
population as determined by the use of iromunofluorescence 
assay using fluorescein-conjugated rabbit anti-bovine IgM 
(107). There was a corresponding decrease 
in the absolute number of T lymphocytes using E—rosette 
formation for enumeration of these cells. A decrease in
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the concentration of IgM in the serum was also observed 
using quantitative radial immunodiffusion. The data 
reported suggest that BLV-infection may induce a state of 
immunosuppression.
A comparison of the absolute numbers of bovine T 
lymphocytes in the peripheral blood of adult asymptomatic or 
aleukemic (AL), PL and BLV-negative cattle may indicate that 
there is an expansion or depletion of these cells m  either 
AL or PL animals. This alteration in T lymphocyte numbers 
may indicate that the T lymphocyte population is affected by 
BLV infection.
Identification of peripheral blood lymphocytes of 
cattle has been performed mainly on animals which exhibit PL 
or LS <110*72,51,156*46). Very few studies have been 
reported on the AL animal (72). Techniques which have been 
used to identify bovine B lymphocytes in BLV-infected cattle 
include the EAC resetting technique (142) and Fc receptor
(85) and surface immunoglobulin (slg) immunofluoresence 
assays (110,B5,). Techniques which have been used for 
bovine T lymphocyte enumeration include E-rc-sette formation, 
(142) an assay for terminal deoxynucleotidy1 transferase 
activity (71), anti—thymocyte serum (ATS) and peanut 
agglutinin (PNA) cell surface fluorescence assays <B4,147>. 
The use of the above techniques for T lymphocyte 
enumeration has led to conflicting reports as to the numbers 
of these cells in normal and BLV-infected cattle.
Recently, specific monoclonal antibodies (MAbs) that
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distinguish bovine T and B lymphocytes have been developed 
and characterized (90). An anti-pan T cell antibody (B26a) 
that reacts with the sheep red cell receptor on the surface 
of T lymphocytes and an anti—IgM antibody'(PIgASA) that 
reacts with cell surface IgM (slgM) have been characterized 
as markers for bovine T and B lymphocytes) respectively 
(90). The specificities of these two MAbs mere determined 
using microcytotoxicity) dual fluorescence microscopy) and 
flow microfluorimetry (FMF).
The present investigation was undertaken to determine the 
frequencies and absolute number of bovine T and B 
lymphocytes in the peripheral blood of AL and PL animals by 
FliF using MAbs that distinguish these cells. MAbs and 
fluorescein labelled PNA (PNA—FITC) were used for T 
lymphocyte enumeration anti— IgM and fluorescein labelled 
rabbit anti-bovine immunoglobulin (Rblg—FITC) for B 
lymphocyte enumeration.
XII. B. MATERIALS AND METHODS
III. B. 1. Animals
A total of 12 cows at least 3 years of age were used in 
this study. Animals were acquired from sale barns in 
Southern Louisiana and were maintained at the Veterinary 
Medical Farm of the Louisisana State University Agricultural 
Center) Louisiana State University School of Veterinary 
Medicine) Baton Rouge) Louisiana. The BLV infection status
was monitored by detection of serum antibodies to BLV 
structural antigens using the agar gel immunodiffusion assay 
<49). Of the 12 cattle tested* 4 were negative for BLV 
antibodies* 4 were clinically normal but had BLV antibodies 
<AL), and 4 were diagnosed as having PL using the criteria 
of the International Conference on Bovine Leukosis (> 7.? x 
ID3* lymphocytes/mm3 of whole blood for over a period of 3 
months) <2). Animals were also vaccinated for various 
bovine viral diseases and screened for infection by other 
lymphotrophic retroviruses* bovine syncytial virus (BSV) and 
bovine visna-like virus <EVV). (For details* see Chapter 
VIZI and Table VIII. 1.)
III. B. 2. Isolation of Peripheral Blood Mononuclear 
Cells
Peripheral blood was collected by Jugular venipuncture 
into 20 ml vacutainer tubes containing 10 units/ml of 
Pan he pr in’* (Abbott Laboratories). The heparinized blood was 
then diluted in an equal volume of phosphate buffered saline 
(PBS)* pH 7.4. Twenty ml aliquots were layered onto 20 ml 
of sodium diatrizoate/ficoll (Histopaque” 1077* Sigma 
Chemical Co.USA) in 50 cc conical centrifuge tubes (Costar* 
Cambridge MA). The gradients were centrifuged for 30 min at 
1DO0 x g at room temperature* and the bands at the interface 
between the plasma layer and HistopaqueR were collected and 
uashed twice in PBS at 500 x g for 10 min at room 
temperature. Viability counts were performed using the 
trypan blue exclusion method. The cell concentration was
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adjusted to 10 x 10^ cells/ml with PBS. The peripheral 
blood mononuclear cell (PBMC) preparation usually contained 
greater than 95X viable cells and less than 2X contamination 
with granulocytes. (Refer to Figure 111. 1. for flow 
diagram.)
III. B. 3. Complete Blood Counts
Animals were bled by venipuncture every 2-3 weeks for a 
period of 3 months to give a total of A counts per animal. 
Blood was collected in tubes containing
ethylenediaminetetraacetic acid as an anticoagulant. Total 
leukocyte counts were made on an automatic cell counter. 
Blood smears were prepared and stained by the Wright method* 
and differential counts were made.
III. B. 4. Staining CelIs for B and T Lymphocyte 
Enumeration
PBMC were isolated from each animal twice at 30 day 
intervals. To identify B lymphocytes* 3 x 10* PBMC were 
incubated with either 100 ul (0.74 mg/ml) fluorescein- 
conjugated F(ab')=. fragments of rabbit anti—bovine IgG* H &
L chains specific (Rblg—FITC) (Cappel Labs* Cochranvi1le*
PA> or 10 ul (1 mg/ml) of hab PIg45a (14. Davis* Washington 
State University* Pullman* UA.). To identify T lymphocytes* 
3 x lO* PBMC were incubated with either 100 ul (1 mg/ml) 
PNA-FITC (E.Y. Laboratories, U.S.A.) or 10 ul (1 mg/ml) pan 
T cell Mab B26a (W. Davis* Washington State University, 
Pullman* WA.). Cells were incubated for 3D min at 4 C in 
the dark* then washed twice in 1 ml aliquots of PBS with
39
0.02% Nahl3 to prevent antibody‘capping. The washed 
preparations of antibody coated cells (PIg45a and E26a) were 
then reacted with 100 ul cf fluorescein-conjugated goat 
anti-murine IgGf Igrt, IgG mix (GaM-FITC) (Cappel Labs., 
Cochranville, PA>, incubated for 30 min at 4 C and washed as 
described above. All cells were fixed with 1 ml 0.5% 
formalin in PBS NaN3. An aliquot of cells were reacted with 
GaM-FITC as a control for nonspecific binding.
III. B. 5. Detection of F 1uorescence—positive CelIs 
Fluorochrome labelled cells were enumerated by FMF 
(90). The instrument used for screening and analysis was 
the mercury arc lamp based flow cytometer (Becton Dickinson 
Hg—arc F A C S ™  Research Analyzer, Becton Dickinson 
Immunocytometry Systems Inc.* Mountain View, CA). The 
instrument measures individual cells simultaneously for 
fluorescence (autofluorescence and fluorescence imparted by 
fluorochrome—coupled antibodies or other specific 
fluorochrome reagents bound to a cell membrane), size 
(measured by electronic volume) and granularity (measured by 
wide angle light scatter).
Data on 5000 cells were collected in list mode on each 
sample for analysis. Two parameter data, scatter versus 
fluorescence were recorded in dot plot, contour plot (with 
concentric lines outlining areas of highest cell density) 
and isometric display using the data analysis programs 
provided for the Beckton Dickinson Consort 30. The percent 
of labelled cells was determined with the computer program
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by setting a marker at the appropriate channel on a contour 
profile of control cells (exposed to GaM-FITC alone) such 
that 95% of the signal imparted by cells fell between 
channels 10 and 80. Erythrocytes and platelets were 
excluded from analysis by setting the trigger threshold and 
gates to exclude low scatter and low volume signal* thereby 
excluding cells smaller than lymphocytes.
III. B. 6. Statisiteal Analysis
The statistical significance of the total UBC* 
lymphocyte* and absolute B and T lymphocyte counts was 
assessed with an unpaired Student's t test (136).
III. C. RESULTS
III. C. 1.Hemogram
The total UBC and lymphocyte counts used for 
statistical evaluation were obtained from 4 individual 
bleeding times (2-3 weeks apart) for each animal. Four 
animals were evaluated from each group of AL* PL and BLV— 
negative control animals. The mean UBC from BLV—negative 
cattle was 6.7 x 103/mm3 of whole blood* from AL animals*
9.7 x 103/mm3* and from PL animals* 26.5 x lCP/mnr* (Fig.
III.2). The mean lymphocyte counts from BLV—negative cattle 
was 3.3 x lCP/mm3* from AL animals* 5.0 xlO^/mm3* and from 
PL animals was 23.5 x lO^/mwr* (Fig. III. 2). These data 
show that there was a significant increase (p < 0.005) in 
the both the UBC and lymphocyte populations in the 
peripheral blood of AL and PL cattle tested (Table III. 1).
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III. C. 2. Frequencies of T and B Lymphocytes
A FMF analysis of one representative animal from each 
BLV group (BLV-negative* AL and PL animals) was selected to 
demonstrate the staining characteristics of that group. 
Animal R 56 represents the BLV—negative group of animals 
(Fig. III.3). Animal Y 75 represents the AL group (Fig.
III.4) and animal B 10 represents the PL group (Fig. III.5). 
When PNA was reacted with PBMC from BLV-negative, AL and PL 
animals, three patterns of labelling were observed. In 
uninfected animals* T lymphocytes invariably exhibited high 
expressions of the PNA receptors (Fig. III. 3a). B 
lymphocytes and null cells exhibited low expression or 
inapparent expression (i.e.* levels of expression not 
detected by FMF). Cells from animals in the AL phase 
contained a high percentage of brightly stained PNA positive 
cells and a small population of the dimly stained PNA 
positive cells (Fig. III. 4a). In contrast* in cell 
preparations from PL animals* a large population of dimly 
stained PNA positive cells were present and there was only a 
small population of brightly stained cells (Fig. III. 5a>.
When PBMC from normal* AL and PL cattle were reacted 
with B26A (pan T cell antibody)* the positive cells 
corresponded to the brightly staining PNA cells (Figs. III. 
3b*4b*5b). The percentage of B26a positive cells ranged 
from 10—20% fewer than PNA positive cells (Table III. 2). 
There was a decrease in the percentage of labelled cells ( 
PNA or B26a) in the PBMC of PL animals.
Cells which reacted with Rablg—FITC (sly*) and PIg45A 
(slgM-*") corresponded with the percent of dimly staining PNA 
positive cells in all animals tested (Figs.
III.3c,d,4c,d,5c,d). The percentage of slgM* cells 
corresponded with the slg"~ cell population (Table III.2).
In the PL animals, the staining intensity was much greater 
for the slgli* bearing cells than for the slg* cells (Fig.
III. 4c,d>. This indicated that the majority of B 
lymphocytes in the PBMC of these animals were IgM—bearing 
cells and that these cells contain large quantities of IgM 
on their surfaces. The percentage of slgM* cells equaled 
the percentage of slg* cells in most cases (Table III. 2). 
These results indicated that even though the anti— IgM 
antibody was an intact Ig molecule, it was not binding to 
cells other than B lymphocytes via the receptor for the Fc 
portion of the Ig molecule. There was an increase in the 
percentage of both slg“" and slgM* cells in the PBMC of PL 
animals when compared to either AL or BLV—negative control 
animals.
The pattern of labelling differed only in one animal, 
632 (Fig. III. 6). This was a PL animal with a high level 
of lymphocytes (72 x 103/mm3 of whole blood) of which B75i 
were positive for the PIg45A marker (Table III.2). A number 
of slg~ cells appeared to react with both B26A and PIg45A 
suggesting the cells may co-express slg and the B26A 
antigen. The staining characteristics of this animal's PBMC 
showed that the majority of its cells stained very intensely
43
with the PIg45a marker, indicating that these cells had 
large quantities of IgM on their surfaces (Fig. Ill, 6d)
III. C. 3. Absolute Numbers of T and B Lymphocytes
The absolute numbers of T and B lymphocytes (B26a"‘ and 
slgM*) in the PBMC of animals tested were determined by 
multiplying the percentage of these cells by the total 
lymphocyte counts. Four animals in each group of AL and 
BLV-negative control animals and 3 PL animals were used. 
Lymphocytes harvested from 2 bleedings (30 days apart) were 
used in this study. Data on 500P cells were collected for 
each sample tested. The statistical information was 
obtained by using raw data for each group (Table III. 3).
The absolute numbers of B and T lymphocytes in the 
peripheral blood of the BLV-negative* AL and PL animals 
tested are summarized in Figure III. 7. The number of T 
lymphocytes in the PBMC of AL and PL animals was 
significantly higher (significance at the level of (p <
0.DOS) than those of BLV—negative animals (Table III. 3).
The number of B lymphocytes in the FBMC of PL animals was 
significantly higher than that of BLV—negative control 
animals (p < 0.005). There was no significant difference in 
the number of B lymphocytes in the PBMC of AL animals when 
compared to BLV—negative control animals.
Absolute numbers of B and T lymphocytes from the PBMC 
of animal 632 were not averaged into the counts for PL 
animals because under the labelling conditions used in this 
study we were unable to distinguish B from T lymphocytes
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because a cell population appeared to stain with both T and 
B lymphocyte markers.
III. D. DISCUSSION
Monoclonal antibodies were used to determine the 
frequencies of T and B lymphocytes in the peripheral blood 
of AL and PL cattle using monoclonal antibodies that 
distinguish these cells. An overall increase in the 
lymphocyte population in AL and PL animals tested when 
compared to BLV—negative control animals. The increase in 
the lymphocyte numbers of AL animals was attributed to an 
increase in the T but not the B lymphocyte population. In 
the PL animals* an increase in both the T and B lymphocyte 
populations was observed. These experiments indicate that 
not only the B lymphocyte population but also the T 
lymphocyte population may be affected by BLV infection.
In order to assess the increase of B and T lymphocytes 
in the peripheral blood of AL and PL cattle* it was 
important to look at absolute numbers of these cells based 
on their frequencies in the PBMC and relative to the total 
lymphocyte counts. Relying on the percentage of cells alone 
leads to an inaccurate assessment of the number of cells 
present in the circulation of individual animals because of 
the increase in the total lymphocyte numbers in AL and PL 
animals. Most of the information reported on T and B 
lymphocytes in BLV-infected animals is reported as 
percentages not as absolute numbers (72*B5*142). This is
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probably the main reason that the increase of T lymphocytes 
in these animals has gone unnoticed.
The use of MAbs to assay bovine T and B lymphocytes has 
many advantages over other methods of evaluation (i.e. SRBC 
rosetting, enumeration of the Fc receptor positive cells* 
ANAE staining). These methods are tedious* and the results 
have been difficult to reproduce in different laboratories. 
In cattle* these techniques have yielded wide ranges of 
values for peripheral B and T lymphocytes (72*142*84). 
Moreover* it has been demonstrated that up to 10% of E— 
rosetting bovine PBMC may be slg~ (147). The existence of a 
population of T lymphocytes having receptors for the Fc 
fragment of IgG has also been demonstrated (147). These 
findings could account for some for the variability 
previously observed in the characterization of the 
frequencies of T and B lymphocytes in BLV-infected animals. 
In the experiments reported here* an anti—IgM antibody of 
the IgM subclass and F(ab')2 fragments of IgG mere used to 
enumerate bovine B lymphocytes and to avoid possible 
nonspecific staining of other PBMC.
PNA-FITC mas found to stain T lymphocytes brightly and 
B lymphocytes and null cells dimly* forming two distinct 
populations with cells from most animals tested. Cells 
labelled with B26A and Rablg and Pig45A corresponded with 
the brightly and dimly PNA-FITC labelled cells respectively. 
Preliminary studies using dual fluorescence analysis with 
granulocyte free HistopaqueR purified PBMC* fluorescein
labelled PNA versus phycoerythrin—avidin biotinated GaMIg 
revealed B26A reacts with cells expressing a high 
concentration of the PNA receptor and that RbXg—FITC and 
PIg45A react with cells expressing a low concentration of 
PNA (90). Therefore* the data presented in this report is 
in agreement with these findings. The staining 
characteristics of PIg45a closely parallel those of Rablg 
indicating that this marker is highly specific for bovine B 
lymphocytes. These results give further evidence that the 
MAb markers are specific for the lymphocyte subsets.
The staining characteristics of lymphocytes from animal 
632 seem to indicate that there is a subpopulation of 
lymphocytes in some BLV-positive cattle with very high 
lymphocyte, counts that carries both B and T lymphocyte 
markers on their cell surfaces. This is an observation 
consistent with SRBC resetting studies reported previously 
(147). Additional studies by dual fluorescence analysis are 
needed to analyse carefully the antigen expression on the 
cells in this animal. There is also an increase in the 
number of cells that bind the PIg45A MAbs alone. Since this 
antibody is an anti-bovine IgM antibody* it suggests that PL 
is attributable* at least in part* to an ‘increase in the 
number of slgM-bearing lymphocytes. These cells are most 
likely immature (virgin) or memory B lymphocytes (142). 
Perhaps this is the BLV-infected population. This 
hypothesis may be proven by isolating this population of 
cells and performing DNA hybridization on its purified DNA
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with a specific BLV-DNA probe.
Some of the BLV—negative and BLV-infected animals used 
in this study had concurrent infections with other bovine 
lymphotrophic viruses (Table VIII. 1). There did not appear 
to be any correlation between the infection with other 
retroviruses* BSV and B W  and the BLV status (AL or PL) of 
the animals used in the above study. It has been reported
that both BSV and BVV have been found in PL and LS animals
(148* 149*11*96). It was once considered that these viruses 
were responsible for EBL (148*149*11). However* it was 
found that the incidence of infection by these viral agents 
in PL or LS animals was low (<2570* whereas* greater than 
9DTi of animals with EBL have antibodies to BLV antigens. No 
direct connection between either of these virus infections 
and the AL or PL state has ever been established (96).
All AL and PL animals were positive for BLV antibodies 
throughout the course of this study. In cattle with PL* an
increase in the total WBC* lymphocyte count and B lymphocyte
population in the peripheral blood has been documented 
<110*85*72). An elevation in the T lymphocyte population in 
PL animals has not been previously reported. This study is 
also the first documentation of an elevation of the T 
lymphocyte population of AL cattle. Therefore* the data 
obtained from the experiments reported herein suggest that 
there is an alteration in the T lymphocyte numbers of BLV- 
infected animals. Identification of the particular T 
lymphocyte subset that is affected by BLV-infection must
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wait for the development of additional monoclonal antibodies 
to bovine T lymphocyte markers.
The reason for increase in the numbers of T lymphocytes 
in the peripheral blood of AL and PL animals is unclear.
The T lymphocyte may be a target cell for BLV infection and 
as a result of infection there could be a T-cell 
lymphocytosis. To address this hypothesis* DNA from 
purified T lymphocytes of BLV-infected animals must be 
acquired and DNA hybridization analysis must be performed 
using a highly specific BLV—DNA probe. The T lymphocyte 
population may be responding to the presence of a serum 
protein(s) which may augment the mitogenesis of these or a 
subpopulation of T lymphocytes. It has been shown that the 
BLV proviral genome codes for a trans activational 
transcriptional protein (tat? which mediates transcriptional 
activation of BLV proviral gene sequences and perhaps host 
cellular genes (131). Perhaps* this gene product is 
responsible for augmenting the T and B lymphocytosis 
observed in BLV-infected animals.
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©  DILUTED PERIPHERAL BLOOD 
1:2  WITH PB S  
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©  WASHED X 2  WITH PBS,
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Figure III.2. WBC and Lymphocyte Counts fran Peripheral Blood 
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Table III. 1. Statisical Analysis of VJBC and








BLV (-) Vs BLV (AL) 4.942 29 '0.005
BLV (-) VS BLV (PL) 3.322 30 0.005
Lymphoc\rtes
BLV (-) Vs BLV (AL) 5.439 28 0.005
BLV (-) VS BLV (PL) 3.268 29 0.005
BLV (-) = Cattle with no detectable serum antibodies 
to BLV antigens using- iitmunodiffusion test.
BLV (AL) - Cattle with detectable serum antibodies to 
to BLV antigens but have no clinical signs of disease. 
BLV (PL) = Cattle with detectable serum antibodies to 
BLV antigens and have persistent lymphocytosis.
Table III. 2. Frequencies of T and B Lymphocytes from 






Percent o£^Positive Lymphocytes 
% T % B **
PNA B26a SIg SIgM
BLV (AL) 4 82 + 6+ 66 ± 9 16 + 11 21 + 13
BLV (PL) 3 4 5 + 3  3 4 + 6 53 + 16 58 + 11
BLV (-) 4 79 + 11 56 + 12 26 +, 6 26 + 7
632++ 1 44 + 11 57 + 6 87 + 7 77 ±  11
*
BLV Status indicates: BLV (-) = Cattle negative for BLV
antibodies. BLV (AL) = Cattle positive for BLV antibodies 
but no clinical signs. BLV (PL) - Cattle positive for 
BLV antibodies and have persistent lymphocytosis.
**
Frequency of T lymphocytes detected by peanut agglutinin 
(PNA) and monoclonal antibodies to pan T cells using 
microfluorimetry. -
Frequency of Blymphocytes detected by rabbit anti-bovine 
IgG (h & L chains specific) (F(ab’)2 fragments and 
monoclonal antibodies to surface bound IgM using 
microfluorimetry.
+
Mean ar standard deviation 
++
PL animal with high lymphocyte count.
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Table III. 3. Statistical Analysis of T and B Lymphocytes 
frctn Bovine Leukemia Virus Infected Cattle
BLV*





(-) vs BLV (AL) 5.599 12 0.005
BLV (-) vs BLV (PL) 5.382 14 0.005
B Lymphocytes 
BLV (-) vs BLV (AL) 0.132 14 **N.S.
BLV (-) vs BLV (PL) 6.250 12 0.005
*
BLV (-) = Cattle with no detectable serum antibodies 
• to BLV antigens using immunodiffusion test.
BLV (AL) = Cattle with detectable serum antibodies to 
BLV antigens but have no clinical signs of disease. 
BLV (PL) = Cattle with detectable serum antibodies to 
BLV antigens and have persistent lymphocytosis.
* *Not significant at the level P = 0.1.
CHAPTER IV: PURIFICATION OF T LYMPHOCYTES FROM BOVINE
PERIPHERAL BLOOD MONONUCLEAR CELLS USING IMHUNO 
AFFINITY DEPLETION (“PANNING")
IV. A. INTRODUCTION
It has been documented that B lymphocytes are target 
cells for bovine leukemia virus (BLV), the etiologic agent 
of enzootic bovine leukosis (EBL> (8,108,75). The role that 
T lymphocytes play in the disease process is unknown. It 
was demonstrated that there is an increase in the number of 
circulating T lymphocytes in BLV-infected aleukemic (AL> and
"s.persistent'lymphocytotic (PL) animals (Chapter III).
Purified T lymphocyte populations are necessary to determine 
the significance of this increase in the progression of EBL.
There are numerous techniques for purification of T 
lymphocytes from human and mouse peripheral blood 
(£4,86,134). However, no techniques are currently available 
for the efficient separation of large quantities of bovine 
lymphocyte subsets. Purification of peripheral blood 
mononuclear cells (PBMC) is done routinely by centrifugation 
on ficoll of density 1‘.077 g/ml (146). Attempts to 
accomplish further separation of bovine T lymphocyte subsets 
using various techniques have failed to give reproducible 
separation results. Purification of bovine T lymphocytes by 
nylon wool adherence has given high purity of these cells,
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however the yield of purified cells uias less than 37. of the 
original cells applied (121). Antibody-complement 
immunolysis has been used to selectively deplete B 
lymphocytes from PBMC of cattle and enrich the T lymphocyte 
population but recoveries are also law (146).
The efficient separation of murine T lymphocytes has 
been reported using plastic surfaces coated with anti-murine 
immunoglobulin antibodies. This technique is referred to as 
immuno-affinity depletion ('panning") (92). This technique 
has' £-iven good yields of highly purified murine T 
lymphocytes. Polystyrene surfaces have also been employed 
as an insoluble matrix for the affinity reagents used to 
separate lymphocyte subpopulations from other species 
(95jl63). A procedure using “panning" has not been reported 
for the efficient separation of bovine T lymphocytes.
Surface markers have been used to identify bovine 
lymphocytes (Refer to Chapter III). Those cells staining 
with anti-bovine immunoglobulin conjugated with fluorescein 
isothiocyanate (slg-bearing cells) are suggested to be B 
lymphocytes (B5*55)» and those staining with peanut 
agglutinin conjugated with fluorescein isothiocyanate (PNA- 
FITC), T lymphocytes (124*55).
The purpose of the present investigation was to explore 
the application of "panning" to enrich T lymphocytes from 
the PBMC of BLV—infected cattle so that large numbers of 
these cells could be obtained for further testing. The 
"panning" technique is based on the fact that bovine B
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lymphocytes have immunogiobulin <Ig> on their cell surfaces 
and that bovine T lymphocytes do not. Therefore* plastic 
surfaces coated uiith anti-bovine Ig will specifically bind 
and therefore deplete B lymphocytes from PBMC. The T 
lymphocytes can then be recovered from the nonadherent cell 
fraction.
IV. 3. MATERIALS AND METHODS
IV. B. 1. Isolation of Peripheral Blood Mononuclear 
Cells
Forty ml of peripheral blood were obtained by 
venipuncture of the Jugular vein from adult AL cows (Y 12* Y 
32, Y 74) and BLV-negative cows (R 52, R 56) (Refer to 
Chapter VIII). The blood was diluted in an equal volume of 
phosphate buffered saline (FBS), pH 7.4. Twenty ml of 
diluted blood were layered on 20 ml of Histopaque" (density 
1.077 g/ml) (Sigma* U.S.A.), in 50 ml polypropylene* conical 
centrifuge tubes (Costar* U.S.A.) and centrifuged at 1000 x 
g for 30 min at 25 C. Cells at the interface between the 
plasma and Histopaque" phases were removed with sterile 
Pasteur pipettes* washed twice with PBS <500 x g for 10 min 
at 25 C), pooled and resuspended in 2 ml PBS. Cell 
viability was determined by the trypan blue exclusion test* 
and the cell suspension was diluted to a concentration of 
2.0 x IQ7 cells in PBS. (Refer to Figure III.l. for a flow 
diagram.)
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IV. B. 2. Coating Plastic Flasks with Immunogiobulin 
To coat polystyrene tissue culture flasks with anti- 
bovine Ig a previously described procedure (92) was used 
with the following modifications. Two ml (2.5 mg/ml) of 
F(ab')s fragments of rabbit anti—bovine IgG, heavy and light 
chains specific (anti—bovine Ig) (Cappeli U.S.A.) were added 
to each 25 cm2 polystyrene tissue culture flask (Costar, 
U.S.A.). The concentration of anti-bovine Ig was critical? 
if less than 5 mg per flask were used* the yield and purity 
of the T lymphocyte preparation were low. The flasks were 
incubated on a level table for 19-24 hours at 4 C to 
optimize Ig binding. Immediately before use* the unbound 
anti-bQvine Ig was transferred to a new, sterile flask which 
was then stored at 4 C for future use. The Ig-coated flask 
was then washed four times, each time with 5 ml PB5.
IV. B. 3. Affinity **Panning" Procedure
The PBMC were gently agitated to assure a single cell 
suspension. Two ml (4.0 x 107 cells) were added to an Ig- 
coated flask. The flask was placed on a level table and 
gently swirled to assure even distribution of the cells over 
the entire dish. After incubation for 15 min at 25 C, the 
nonadherent cells were carefully resuspended by rocking the 
flask, then removed with a pipette and washed twice with PBS 
(500 x g for 10 min at 25 C). Maximum binding of cells to 
precoated surfaces was determined to occur within fifteen 
minutes of incubation at 25 C. Longer incubation times did 
not increase the cell binding capacity. Shorter incubation
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periods resulted in lower T lymphocyte yield and higher slg— 
bearing cell contamination. Cell viability was determined 
by trypan blue exclusion test, and the cells were 
resuspended to a concentration of 10 x ID*" viable cells/ml 
in PBS to prepare for quantitation of lymphocyte subsets and 
monocytes. (Refer to Figure IV. 1. for a flow diagram.)
IV. B. 4. Determination of Lymphocyte Subsets and 
Monocytes
For detection of contamination with slg bearing cells, 
nonadherent cells were incubated with fluorescein-conjugated 
F(ad')a fragments of rabbit anti-bovine IgG, heavy and 
light chains specific <Rablg-FITC>, (Cappel, U.S.A). To 
detect T lymphocytes, nonadherent cells were incubated with 
PNA-FITC (E.Y. Laboratories, U.S.A.). Approximately, 0.3 ml 
(3.0 x 10^ ) cells were mixed with either 0.1 ml <0.74 
mg/ml) of Rablg-FITC or 0.1 ml (2.5 mg/ml) PNA-FITC. The 
cells were incubated for 30 minutes at 4 C then washed twice 
(500 x g for 10 min at 25 C) with 1 ml of PBS containing 
0.02% NaN3. This concentration of NaN? was used to insure 
that capping and shedding of Igs did not occur on the slg- 
bearing cells.
Rablg-FITC and PNA-FITC positive cells were enumerated 
by counting 200 cells at 1000 x magnification with the aid 
of a fluorescent microscope equipped for phase contrast and 
incident UV light i 11 uni in at ion (Leitz, Germany). The 
detection of monocytes in the nonadherent cell population 




IV. C. 1. T Lymphocyte Vield after "Panning*
The results Df T lymphocyte recovery or yield after 
■panning* using the PBMC of coins are summarized in Figure
IV. 2. An average of 31 x 10** PNA-positive (T lymphocytes) 
were added to an anti— Ig coated flask. After incubation for 
15 minutes, the T lymphocyte recovery in the nonadherent 
fraction averaged 15 x 10** cells. This was an average yield 
of 48%.
IV. C. 2. T Lymphocyte Enrichment and B Lymphocyte 
Depletion
The results of T lymphocyte enrichment from PBMC using 
■panning* are summarized in Figure IV. 3. After separation 
on a density gradient of HistopaqueR, the PBMC fraction 
consisted of an average of 77% T lymphocytes. After 
“panning", the nonadherent cell fraction was composed of an 
average of 95% T lymphccyte population.
An average of 85% of the slg-bearing cells were 
depleted from the PBMC using "panning" (Fig. IV. 4). B 
lymphocytes accounted for an average 3% of the contaminating 
cells in the nonadherent fractions. The rest of the cells 
were not identified by the methods used and were assumed to 
be null cells. Non—specific esterase—positive cells 




An affinity depletion technique for the efficient 
enrichment of bovine T lymphocytes from peripheral blood has 
been described. Antibodies to bovine Igs attached to 
polystyrene tissue culture flasks mere used to separate slg- 
bearing cells from T lymphocytes. The T lymphocyte yield 
and purity using "panning" on the PBMC of cattle is higher 
than any method previously reported. For example* the use of 
nylon wool adherence to deplete B lymphocytes from PBMC 
resulted in high T lymphocyte purity (96%) but low cell 
recovery (2.5%) in the nonadherent fraction (121). However* 
the use of "panning" resulted in a 95% T lymphocyte purity 
and 48% recovery.
This technique gave reproducible results with BLV- 
infected AL animals (Y 12* Y 32 and Y 74) and BLV-negative 
control animals (R 52 and R 54) which had normal white cell 
counts in the range of 6.8-9.B x lCF/mm3 in whole blood and 
52—64% lymphocytes (121). “Panning" did not give good 
yields (< 10%) of purified T lymphocytes from PBMC of BLV- 
infected cattle which exhibited a persistent B cell 
lymphocytosis (PL). These animals typically had elevated 
WBC (> 7.5 x lCP/mm3 in whole blood). They also had a high 
percentage of lymphocytes (> 50%)* of which the majority (> 
60%) were slg-bearing cells. When PBMC from these animals
were added to an anti-Ig coated flasks, the number of slg- 
bearing cell binding sites on the flask apparently became 
saturated* and the nonadherent cell fraction mas highly 
contaminated with slg-bearing cells. Therefore, in order to 
obtain an efficient T lymphocyte recovery with high purity, 
modification of the above procedure was attempted. A second 
■panning" step to remove the slg—bearing cells not bound by 
the first "panning" was employed. This technique did not 
give good yields of highly purified T lymphocytes. 0trier 
separation techniques such as B lymphocyte depletion by 
antibody, complement-mediated cytolysis (14&), and 
separation on PercollR density gradients as well as affinity 
column chromatography using Affi-Gel anti—FITC columns < 
BioRad, U.S.A.) were used to attempt to purify T lymphocytes 
from the PBMC of PL cattle. No procedure gave good yields 
of purified T lymphocytes from these animals.
The affinity "panning" for efficient enrichment of 
bovine T lymphocytes from PBMC of normal and AL cattle was a 
simple, reproducible method that gave a highly purified, 
viable T cell population in as little as two hours. The 
procedure used a minimal amount of reagents, and the unbound 
anti— Ig could be transferred and used up to three times 
without loss of T lymphocyte purity or yield. The technique 
yielded 20-40 >: ID*5* T lymphocytes from 40 ml of whole blood.
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Figure IV.4. Depletion of B Lymphocytes by "Panning" of BovinePeripheral Blood Mononuclear Cells using Anti-BovineImmunoglobulin Coated Flasks.
CHAPTER V: ASSESSMENT OF THE PRESENCE OF BLV PROVIRUS IN
THE T LYMPHOCYTES OF BLV-INFECTED* ALEUKEMIC CATTLE
V. A. INTRODUCTION
The bovine leukemia virus (BLV)* an exogenous (14) 
leukemogenic virus of the family Retroviridae* has been 
implicated as the etiologic agent of enzootic bovine 
leukosis (EBL) (108). This virus may infect cattle and not 
produce any clinical signs of disease. These animals are 
referred to as aleukemic (AL) cattle. The virus may also 
induce two clinical manifestations of diseasepersistent 
lymphocytosis (PL) or malignant lymphosarcoma (LS) (46). 
Since* EBL is a neoplasm of the lymphoid system* cells of 
the lymphocyte lineage were the first candidates to be 
suspected as preferred BLV targets. This was shown to be 
correct by demonstration of BLV production in vitro from 
cultures of peripheral blood mononuclear cells (PBMC) from 
BLV-infected cattle (108). Also* molecular hybridization 
analysis using a single-stranded BLV cDNA probe for 
detection of BLV proviral sequences in the white blood cells 
of PL cattle confirmed the presence of BLV in the 
lymphocytes of these animals (76).
By using the nylon wool separation procedure to 
fractionate the B and non—B populations of bovine peripheral 
blood and subsequent in vitro cultivation of these cells* it 
was shown that the capacity to produce C-type particles 
resided with the B lymphocytes (124).
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It was also found that the majority of lymphocytes present
in the peripheral blood of PL and LS cattle and in tumors
had markers typical of B lymphocytes (110,85,72). This 
information led to the conclusion that the B lymphocyte is 
the target cell of BLV infection. A recent study indicated 
that lymphoblastoid-l ike cells derived from two EBL tumors 
had cell surface markers typical of T lymphocytes and that 
the cells from these cultures contained BLV provirus (91).
It has been demonstrated that there is an increase in the
absolute number of T lymphocytes in the peripheral blood of
AL and PL animals (Chapter 111). These studies suggest that 
T lymphocytes of BLV-infected animals may either be infected 
by BLV or are responding to the presence of the virus or 
viral proteins.
Definitive studies on highly purified T lymphocyte 
populations from the peripheral blood of animals with AL or 
PL have not been conducted. The main reason that this 
research has not been done is that purification techniques 
which yield large quantities of highly purified T lymphocyte 
preparations have not been available. A technique using 
immuno-affinity depletion "panning* to deplete B lymphocytes 
from PBMC of cattle has recently been reported (Chapter IV, 
ld»l). This technique gives good yields of highly purified 
bovine T lymphocytes from AL but not PL animals.
The purpose of this investigation was to assess the 
presence of the BLV provirus in the DNA of immuno—affinity 
purified bovine T lymphocytes from AL cattle using DNA
hybridization with a highly specific* nick-translated 3ap— 
BLV-DNA cloned probe.
V- B. MATERIALS AND METHODS
V. B. 1. Animals
A total of 7 animals were used in this study (R 52* Y 
73* Y 12* Y 32* Y 74, Y 75 and B 10). (For more details 
refer to Chapter VIII and Table VIII. 1.) The cattle were 
examined clinically and hematologically for signs of bovine 
leukosis using the guidelines of the International 
Conference of Bovine Leukosis (2). BLV infection was 
monitored by detection of serum antibodies to Bi_V structural 
antigens using the agar gel immunodiffusion assay (33). Of 
the 7 animals* 2 were BLV-negative* 4 were AL and 1 one was 
a PL animal.
V. B. 2. Isolation of PBMC
Large quantities of cells were required <1 x 10B 
cells) for DNA purification. Therefore* 5DD ml of 
peripheral blood were collected by venipuncture into vacuum 
bottles containing Panheparinw* 10 units/ml whole blood 
(Abbott Laboratories, U.S.A.). The heparinized blood was 
then diluted in an equal volume of phosphate buffered saline 
(PBS)* pH 7.4. Twenty ml aliquots were layered onto equal 
volumes of sodium diatrizoate/ficol1 * 1.077 g/ml 
(Histopaque** 1077* Sigma Chemical Co. * U.S.A. ) in 50 cc 
conical centrifuge tubes (Costar* U.S.A.). The gradients
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uere centrifuged for 30 min at 1000 x g at room temperature. 
The bands at the interface between the plasma layer and 
HistopaqueR were collected and washed twice in PBS at 500 x 
g for 10 min at room temperature. Viability counts were 
performed using the trypan blue exclusion method. The 
lymphocyte preparation usually contained greater than 7b5i 
viable cells. (Refer to Figure III. 1 for flow diagram).
V. B. 3. Purification of T Lymphocytes
The T lymphocytes were purified from PBMC of BLV— 
negative and AL cattle by immuno—affinity depletion 
("panning*)i a method previously described (Refer to Chapter
IV.). Briefly* 4 x IG'7’ PBMC were added to each of six 25 
cm2* polystyrene tissue culture flasks (Costar* U.S.A.). 
These flasks had been previously coated with 5 mg of F(ab')2 
fragments of rabbit anti—bovine IgG* H and L chains specific 
(anti—bov IgG) (Cappel* U.S.A.)* and incubated for at least 
IB hours at 4 C. The unbound anti-bov IgG was then removed* 
and the coated flasks were washed x 4 with 5 ml of PBS. The 
cells were incubated in the immunoglobulin-coated flasks at 
25 C for 15 min. After incubation* the nonadherent cells 
were carefully resuspended by rocking the flask* then 
removed with a pipette and washed twice with PBS. (Refer to 
Figure IV. 2. for flow diagram). The nonadherent cell 
preparation usually contained 40-502 of the original number 
of cells applied.
V. B. 4. Determination of Lymphocyte Subsets and 
Monocytes
For detection of B lymphocytes in PBMC and purified T 
lymphocyte preparations, 3 x 10** cells were mixed with 100 
ul CO.74 mg/ml) of fluorescein—conjugated F(ab')2 fragments 
of rabbit anti—bovine IgG* H and L chains specific (Rablg- 
FITC) (Cappel* U.S.A.). This marker has been shown to be 
highly specific for bovine B lymphocytes (refer to Chapter 
III). For detection of T lymphocytes! nonadherent cells 
were mixed with 100 ul (2.5 mg/ml) of fluorescein-conjugated 
peanut agglutinin—FITC (PNA-FITC) (Cappelf U.S.A.). This 
marker has been shown to label bovine T lymphocytes (Refer 
to Chapter III). All cell preparations were incubated for 
30 minutes at 4 C* then washed twice with 1 ml of PBS 
containing 0.02% NaN3 to prevent antibody capping.
Fluorescence-positive cells were enumerated by counting 
200 cells at 1000 x magnification with the aid of a 
fluorescent microscope equipped for phase contrast and 
incident UV light illumination (Leitz* Germany). The 
detection of monocytes in the T lymphocyte preparations was 
accomplished by using the nonspecific esterase staining 
procedure < 63).
V. B. 5. DNA Purification
DNA purification of PBMC and T lymphocyte preparations 
was performed as previously described with the following 
modifications (101). Briefly* 1 x 10s cells were lysed in 
DNA lysing medium (10 mM Tris buffer pH 7.4* lOmM 
ethylenediaminetetraacetic acid (EDTAf 0.1 M NaCl* 1.0% 
Sarcosyl and 10D ug/ml Protease K* Sigma Chemical Co
U.S.A.). The lysate was digested for 45 min. at 37 C then 
either promptly extracted or frozen at —70 C. The lysates 
were extracted 2 x with equal volumes of chloroform:isoamyl 
alcohol mixture (24:1) (centrifuged 2*500 x g for 20 min at 
25 C). The chloroform was removed by two cycles of ether 
extraction using an equal volume of H20 saturated ether. 
Residual chloroform and ether was removed by heating the 
preparation to 6B C for 10 min. The salt concentration of 
the DNA preparation was adjusted to 0.5 M NaCl. The DNA was 
ethanol precipitated with two volumes of ethanol for at 
least 2 hrs at -20 C. The precipitate was pelleted at 
15*000 x g for 15 min at 4 C and resuspended in 1-2, ml Tris 
EDTA (TLE) buffer (lOmM Tris, pH 7.4 and 0.1 M EDTA). The 
concentration of DNA was assessed by spectrophotometric 
means using 0D2M3 for DNA concentration quantitation and 
0D2 M ,/0D2OO ratio as an estimate of purity (135). One 
optical density at 260nm was equal to 50ug of DNA. A ratio 
of from 1.8 to 2.0 (0D2<>o/0D2tsc,) was considered of good 
purity. The DNA was stored at —20 C until used. (Refer to 
Figure V. 1. for flow diagram.)
V. B. 6. Restriction Endonuclease Digestion and Gel 
Electrophoresis 
Sac 1 restriction endonuclease (R.E.) (Cooper 
Biomedical* U.S.A.) digestions were carried out on the 
bovine PBMC and T lymphocyte DNA's using the following 
method. Approximately 5 ug of DNA was mixed with 5 ul of 
ID X Sac 1 buffer <60 mM NaCl, 6D mM Tris, pH 7.4, 60 mM
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MgCl, 60 mM 2-mercaptoethanol, and 100 ug/rol bovine serum 
albumin), 5 ul of Sac 1 R.E. (10 units/ul), and H^O to make 
a 50 ul reaction mixture. This mixture was incubated for 2 
hr at 37 C. After digestion was complete, 5 ul of DNA 
loading dye (0.25% bromophenol blue, 0.25% xylene cyanol, 
and 15% ficoll type 400) was added tD the digests. The 
reaction mixtures were loaded into individual wells of 
horizontal, 0.7% agarose (SeaChem agarose FMC U.S.A.) slab 
gels. The Hind III digest of lambda DNA and the Haelll 
fragments of 0X174 RF DNA (New England BioLabs, MA) were 
used as molecular-weight markers. Sac 1 digest of DNA from 
the fetal lamb kidney cell line which is persistently 
infected with BLV (FL.K—BLV) (153) as well as DNA from PBMC 
of PL animal B ID were used as BLV-DNA positive controls.
Sac 1 digests from PBMC and purified T lymphocyte 
preparations from BLV-negatiive cows were used as negative 
controls. The DNA was electrophoresed in Tris acetate 
buffer (TAE) (0.04 M Tris acetate and 0.002 M EDTA). at 30 V 
for 16 hr at 25 C. The gel was then stained for 30 min using 
ethidium bromide (EtBr) (5 ug/ml) and photographed using 
long wave UV light illumination and Polaroid Type 57 film.
V. B. 7. Gel Transfer
DNA fragments were transferred from agarose gels to 
nitrocellulose filters using the Southern transfer technique 
(137). Nitrocellulose filters were then dried for 2 hr at 
60 C in a vacuum oven.
V. B. 8. BLV-DNA Probe
The BLV DNA probe was provided by Dr. James Casey 
(Frederick Cancer Res. Inst. Fredrick* MD.) as a cloned 
provirus probe consisting of an EcoRl fragment of FLK-BLV 
DNA which contained almost the entire BLV provirus excluding 
the 3' long terminal repeat and included 20D base pairs of 
cellular flanking sequence DNA (Fig. V. 2). This fragment 
was ligated into a PUC-S vector plasmid and cloned in E. 
coli HB101. This probe hybridized to the 7.5 kilobase (Kb) 
fragment of the BLV-provirus DNA in BLV-infected lymphocytes 
but hybridization also occurred with a variety of other 
fragments in these DNAs and in BLV—negative control animals. 
Therefore* the cloned probe was further purified as 
described below.
The BLV-DNA probe (ID ug) was digested with Sac 1 to 
purify almost the entire BLV proviral genome as a 7.5 Kb ' 
fragment ( Fig. V. 2). The R.E. fragments were then 
separated by agarose gel electrophoresis using a 0.7'i 
horizontal agarose gel at 30 V for 16 hr in TAE buffer. The 
gel was then stained with EtBr to visualize the R. E. 
fragments. A 2 mm wide trough was cut in front of the 
leading edge of the 7.5 Kb fragment* and the trough was 
filled with electrophoresis buffer. The band was then 
observed by UV light as it was electroeluted from the gel 
into the trough at 200 V. Every 30 to 40 seconds the fluid 
from the trough was recovered* and the trough was refilled 
with fresh buffer. Electrophoresis was then continued until 
all the DNA in the band was removed from the gel and was
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recovered in the fluid taken from the trough (Fig. V. 3).
The probe was further purified of contaminating gel 
components by ion—exchange chromatography using a nucleic 
acids chromatography column (NACS PREPAC™ mini-column) 
(Bethesda Research Laboratories* MA). The DNA mas 
precipitated in two volumes of cold ethanol at -20 C for 2 
hr and then pelleted at 15*000 x g* 15 min* A C. The pellet 
was resuspended in 20 ul TLE.
V. B. 9. Nick Translation of BLV-DNA Probe
The BLV-DNA probe was radiolabelled with a-32P labelled 
deoxycytosine triphosphate (dCTP Ca-^^Pl) by nick- 
translation using a Nick Translation Kit” (Cooper 
Biomedical* PA). Briefly* 2 ug of BLV-DNA* 5 ul of nick 
translation buffer* 1 ul of each of dATP* dTTP and dGTP* 10 
ul of dCTP Ca—33rP3 (10 mCi/ml) (New England Nuclear* MA), 2 
ul of DNAase 1/ DNA polymerase I mixture and H^O were added 
to make a 50 ul reaction mixture. The mixture was incubated 
at 18 C for 1 hour* and the reaction stopped with 20 mM 
EDTA. The unincorporated isotope was removed from the nick- 
translated DNA using gel filtration chromatography using a 
MINI—SPIN” column (Cooper Biomedical, PA). This column 
consisted of a pre—hydrated* prepacked column of Sephadex* 
G-50. The nick-translated probe was then dissociated into 
single-stranded DNA by the addition of 1/10**' volume of 2 M 
NaOH. The specific activity of the radiolabelled probe was 
determined by scintillation counting of the probe using Hz0 
as a scintillation medium (Packard Tricarb Scintillation
ea
Counters USA).
V. B. 9. Filter Hybridization
Nitrocellulose filters were prehybridized in 
hybridization mixture (103) for 48 hr at 37 C.
Hybridization was carried out by adding 1.5 x ID7 cpm of the 
single-strandedt nick translated 33P-BLV DNA cloned probe in 
B ml of hybridization buffer. The filters were wrapped x 2 
in SaranR wrap and once in aluminum foil. The filters were 
incubated for 48 hr at 37 C* washed for 1 hr in a .high salt 
solution <2x SSC and 0.5% sodium dodecyl sulfate (SDS) at 37 
C and for 2 hr in a low salt solution (0-lx SSC and 0.5%
SDS) (104) at 45 C. Filters were dried at 60 C for 1 hr.
V. B 10. Autoradiography
Filters were exposed at -70 C to Kodak X RP-5 X—Omat 
film in the presence of 2 Cronexj Lightning Plus'S 
intensifying screens (Dupont( U.S.A.) for 2-5 days. The 
exposed film was then developed using a Kodak X-Omat 
Processor (Kodak T USA).
V. C. RESULTS
V. C. 1. Purity of T Lymphocyte Preparations
The frequency of T and B lymphocytes in the PBMC and 
purified T lymphocyte preparations used for DNA 
hybridization analysis can be found in Table V. 1. The 
frequency of T lymphocytes in the PBMC of AL and BLV- 
negative control animals ranged from 69 to 89%. The
81
frequency of B lymphocytes in the PBMC of these animals 
ranged from 15 to 23%. In the purified T lymphocyte 
preparations* frequencies of T lymphocytes ranged from 91 to 
97%* and frequencies of B lymphocytes ranged from 0 to 4%.
Based on 1 x 10s cells (quantity of cells iysed for DNA 
purification) the absolute number of contaminating B 
lymphocytes were estimated for each DNA preparation.
Animals Y 12 and Y 74 were assumed to have no B lymphocytes 
in their purified T lymphocyte preparations* whereas* in the 
PBMC of these animals there were 5 x 10* and 13 x 10* B 
lymphocytes* respectively. In the purified T lymphocyte 
preparation of animal Y 75* there were 3 x 10* B lymphocytes
f
versus 23 x 10* B lymphocytes found in the PBMC of this 
animal. In the T lymphocyte preparation of animal Y 32* 
there were 4 x 10* Blymphocytes versus 27 x 10* B 
lymphocytes found in the PBMC of this animal.
V. C. 2. Agarose Gel Electrophoresis
Results of the agarose gel electrophoresis of R. E. 
fragments show that test DNA was present in relatively equal 
concentrations in each of the lanes of the gel. Also* the 
enzyme Sac 1 effectively digested the DNA's as evidenced by 
detection of the highly repetitive DNA sequences (Fig. V. 3)
V. C. 3. DNA Hybridization Analysis
As shown in Figures V. 5 & 6* “̂ P-labeled BLV DNA 
hybridized on the 7.5 Kb Sac 1 fragment from the PBMC of all 
BLV-positive AL and PL cattle and the FLK-BLV positive 
control DNA. No hybridization was observed to the DNA
fragments from BLV—negative cattle. DNA from the purified T 
lymphocyte preparations of 3 AL animals (Y 74, Y 75, and Y 
32) were positive for hybridization on the 7.5 Kb Sac 1 
fragment with the BLV-DNA probe. The quantity of DNA which 
hybridized with the probe appeared to be much lower in the 
purified T lymphocyte DNA preparations than in the 
respective PBMC DNA preparations because the respective 
bands on the autoradiographs were much less dense than those 
of the PBMC DNA preparations. Cow Y 74 contained no 
detectable B lymphocytes in the purified T lymphocyte 
preparation but its DNA gave a positive hybridization signal 
with the BLV-DNA probe. Cow Y 12 which also contained no 
detectable B lymphocytes in the purified T lymphocyte 
preparation gave negative hybridization results.
V. D. DISCUSSION
The purpose of this study was to determine if bovine T 
lymphocytes were targets for BLV infection. Results from 
the experiments reported herein suggest that bovine T 
lymphocytes of some AL cattle contain the BLV provirus. The 
BLV provirus was detected in the DNA of PBMC from all AL 
animals and also in the DNA of 3 of 4 purified T lymphocyte 
preparations from AL animals. Two of the T lymphocyte 
preparations which gave positive hybridization results 
contained only small amounts of contaminating B lymphocytes 
(3 and 4%). It has been well documented that the B
lymphocyte is a target for BLV infection (45,108,121). 
Therefore, it is possible that the positive hybridization 
results obtained from the DNA of these 2 cel) preparations 
were due to the DNA from contaminating BLV-infected B 
lymphocytes. Less than 25% of B lymphocytes from BLV- 
infected animal5 have been shown to produce viral particles 
or display viral antigens on their cell surfaces after short 
term incubation (121,73). Therefore, less than 10 x 10s 
BLV-infected B lymphocytes were possibly present in the 
purified T lymphocyte preparations. It is possible that 
this amount of BLV-infected lymphocyte DNA can give a 
hybridization signal because of the sensitivity of the solid 
Phase hybridization procedure. The sensitivity of the solid 
phase DNA hybridization assay is such that it can detect 1 
proviral copy in 10. (personal communication Dr. James 
Casey, National Cancer Institute, Fredrick, tiD). When 
comparisons of the percentage of B lymphocyte DNA in the 
purified T lymphocyte preparations and the percentage of B 
lymphocyte DNA in the PBMC of the same animals were made 
with their respective hybridization signals on the 
autoradiographs, it appeared that the signals generated by 
the purified T lymphocyte DNA preparations were greater than 
what would be expected if only B lymphocytes contained the 
BLV provirus.
One purified T lymphocyte preparation (animal Y 74) 
contained no detectable B lymphocytes. The DNA from this 
cell preparation gave positive hybridization results. It is
possible that a population of slg- B lymphocytes exists in 
cattle* but this has not been reported. The marker used in 
this study to enumerate bovine B lymphocytes has been shown 
to be highly specific for bovine peripheral blood B 
lymphocytes (55*90*85). The lymphocyte surface marker 
profile of this animal appeared normal using flow 
microfluorimetry (FMF) (Chapter III). Monoclonal antibodies 
(MAbs) against surface bound IgM (PIg45a> and Rablg-FITC 
markers for B lymphocyte enumeration and MAbs against T 
lymphocyte surface antigens and PNA receptors for T 
lymphocyte enumeration were used in the FMF assays (Chapter
III).
One additional AL animal (Y 12) had no detectable B 
lymphocytes in the purified T lymphocyte preparation. 
However* the DNA from this preparation' gave no hybridization 
with the BLV—DNA probe. The DNA of the PBMC from this 
animal gave a weaker hybridization signal than the DNA from 
other AL animals and this indicated that fewer cells 
contained the BLV provirus. The BLV-infected T lymphocytes 
may have been depleted in the “panning* procedure since the 
average yield of T lymphocytes from “panning" is 48 % of the 
original number of T lymphocytes applied to the “panning" 
flask (Refer to Figure VI. 2). Another possibility is that 
not all AL animals have detectable levels of BLV-infected T 
lymphocytes.
This study documents the first attempt to assess the 
presence of the BLV provirus in highly purified peripheral
blood T lymphocyte populations from BLV-infected AL cattle. 
Hybridization studies reported to date using highly specific 
BLV-DNA probes and buffy coat preparations or PBMC* 
demonstrated that the BLV provirus was present in the 
lymphocyte population (75*76). It was also shown that the 
ability to produce C-type viral particles resided with the B 
lymphocyte subset (121). However* definitive studies on 
highly purified peripheral blood lymphocyte subsets had not 
been reported. A recent report showed that lymphoblastoid- 
like cells derived from two EBL tumors not only had markers 
of the T lymphocyte lineage but also contained the BLV 
provirus (91). Therefore, it appeared that bovine T 
lymphocyte population of BLV-infected animals may be 
infected with the BLV provirus.
The results of this study suggest that the B lymphocyte 
is the major target cell of BLV infection in the AL animal. 
After B lymphocytes were depleted from PBMC using "panning" 
with anti-bovine Ig* the amount of DNA in the "panned” cell 
preparation which hybridized with the 32P BLV—DNA probe was 
greatly reduced. This indicates that a large number of BLV- 
infected cells (B lymphocytes) were removed by the "panning” 
procedure. This study also suggests that the BLV provirus 
can be detected in the DNA of T lymphocytes of some AL 
animals. It appears that only a small number of these cells 
are infected by the virus* as evidenced by the weak 
hybridization signal from the purified T lymphocyte DNA 
preparations. Therefore, BLV may infect only a
subpopulation of T lymphocytes in the peripheral blood of AL 
animals. Infection of this cell population may alter 
function of these cells and thereby facilitate the 
transition from the AL to PL stage of EBL. Possibly* 
infection of the T lymphocytes is a prerequisite for the 
progression to the PL state. In order to address this 
hypothesis* purified T lymphocytes from PL animals must be 
screened for BLV provirus. The purification techniques 
which were used in this study for T lymphocyte purification 
were not applicable to PBMC of PL animals (Refer to Chapter
IV). This was probablly due to the very low frequencies of 
T lymphocytes present in the PBMC preparations.
The question of whether BLV infects cells of the T 
lymphocyte lineage is of importance for the use of EBL as a 
model for the viral-incuced human adult T cell leukemia 
(ATL) associated with human T cell leukemia virus (HTLV I) 
(162). Many aspects of the disease induced by HTLV I 
parallel those of EBL (162*121). The disease is typically 
chronic. Lymphocytosis occurs in some cases as do 
immunodefficiencies. Lymphoma occurs in a small percentage 
of infected individuals. A major difference between ATL and 
EBL is that the target cell of HTLV I appears to be the T 
lymphocyte and the major target cell of BLV appears to be 
the B lymphocyte (162* 121). The data presented here 
indicate that bovine T lymphocytes may also act as targets 
for infection by BLV and therefore* this information may 
contribute to the BLV model of HTLV—induced leukemogenesis.
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Figure V.3. Purification of BLV DNA Probe Using Electroelution 
of BLV DNA Sac 1 Fragment from an Agarose Gel.
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Figure V.4. Gel Electrophoresis of Sac 1 Restriction Enzyme 
Fragments of Lymphocyte DNA.
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Figure V.5. DNA Hybridization Analysis of Peripheral Blood
Mononuclear Cells and Purified T Lymphocytes from 
Bovine Leukemia Virus-Infected Cattle Using a -*2p 
BLV-DNA Probe.
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Figure V. 6. DNA Hybridization Analysis of Peripheral Blood
Mononuclear Cells and Purified T Lymphocytes from 




Table V. 1 — Frequencies of T and B Lymphocytes 







% T a % B b % T % B
BLV (AL)c 
Y 74 79 13 97 0
Y 75 76 23 91 3
Y 32 69 27 95 4
Y 12 79 5 95 0
BLV (— )d
R 52 69 20 ND ND
Y 73 73 22 94 2
aCells positive for fluorescence using PNA-FITC. 
^Cells positive for fluorescence using Rablg-FITC. 
cBovine leukemia virus positive, aleukemic state.
No detectable antibodies to bovine leukemia virus.
CHAPTER VI: EVALUATION OF THE RESPONSES OF LYMPHOCYTES OF
ALEUKEMIC AND PERSISTENT LYMPHOCYTOTIC CATTLE TO 
SELECTED PHYTOMITOGENS
VI- A. INTRODUCTION
Approximately 30% of cattle infected with bovine 
leukemia virus (BLV) develop a benign condition referred to 
as persistent lymphocytosis (PL) (10B). The PL state is 
characterized as a persistent elevation of primarily B 
lymphocytes in the peripheral blood (108). Animals with PL 
develop clinical lymphosarcoma (LS) more frequently than do 
BLV-infected) aleukemic (AL) cattle which have no clinical 
signs (51). Therefore) the transition from the AL to PL 
state may be a primary step in the progression of the 
disease to the tumor state.
It is unclear what factor(s) mediate the switch from 
the AL to the PL stage or allow for the uncontrolled B-cell 
lymphocytosis. A possible factor may be a modulation of a 
specific T-helper or suppressor cell population that elicit 
soluble factors which help to regulate B lymphocyte 
proliferation (81). However) little is known about the 
immunological and functional properties of lymphocytes of AL 
or PL cattle.
It has been demonstrated in other leukomogenic 
retroviral infections (human adult T cell leukemia (ATL)) 
feline leukemia) murine leukemia) avian leukemia)
94
that immunosuppression takes place as a result of retroviral 
modulation of immune cells (13* 159* 26). Immunosuppression 
may occur as a result of the interaction of BLV with its 
target cells. It has been documented that the B lymphocyte 
is a target cell for BLV infection (45*73*76). It has also 
been demonstrated that the T lymphocytes from the peripheral 
blood of some AL animals and tumors of some LS animals 
contain the BLV provirus (Chapter Vf9i). An increase in 
the absolute T lymphocyte numbers in AL animals and an 
increase in the absolute number T and B lymphocytes in PL 
animals has also been observed (Chapter 111*142). It is 
unclear whether these factors affect T lymphocyte function 
in BLV-infected animals.
The mitogenic stimulation of lymphocytes as measured by 
uptake of 3H thymidine is used to evaluate inherited and 
acquired immunodeficiencies and the effect of the 
iiwnunoenhancing or immunosuppressive action of serum factors 
(4* 112*157). This technique can therefore be used as an 
indicator of lymphocyte function. Mitogens such as 
phytohemagglutinin (PHA>* Concanavalin A (Con A) and 
pokeweed (PWW) have been used tD assess the mitogenic 
response of bovine lymphocytes (111*112*132*157). The PHA 
and Con A responsiveness is a property of bovine thymus- 
derived lymphocytes <T lymphocytes) (111*132) and the PWM 
responsiveness is a property of both T and B lymphocytes 
because a B lymphocyte mitogen requires the presence of T 
lymphocyte soluble factors to obtain a full blastogenic
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response (111,132).
In studies with BLV-infected animals* the lymphocyte 
response to PWM and PHA* as indicated by the use of 
stimulation index (S.I.), was markedly less for those cells 
obtained from animals with PL than for those obtained from 
hematologically normal animals (112). The lymphocytes from 
cows with PL that were cultured without phytomitogens 
incorporated approximately 5 times more tritiated thymidine 
than did lymphocytes from normal animals (112). It was 
also shown that the lymphocyte stimulation of AL animals 
appeared to be normal when blastogenesis assays were 
conducted using PHA as the mitogen (68). Another study 
suggested that the stimulatory effect of Con A on 
lymphocytes of PL- cattle was significantly depressed when 
compared to response using normal lymphocytes (157). These 
results suggested that the T lymphocyte population of PL 
animals may be functionally affected in the ability to 
respond to mitogens. However* the depressed stimulation may 
have been the result of low numbers of T lymphocytes present 
in the lymphocyte preparations of PL cattle used in the in 
vitro blastogenesis assays or because stimulation index was 
used to assess the responsiveness to mitogens. These
questions have not been fully considered.
Inhibition of lymphocyte blastogenesis of normal 
lymphocytes by sera from cows with LS has been shown but 
suppression has not been demonstrated with the sera from PL 
or AL cattle (164). If present* these serum factors may
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affect immunoregulation.
The purpose of the present investigation was to compare 
the response of lymphocytes from AL and PL cattle to 
phytomitogens PHA, ConA* and PWM using the in vitro 
lymphocyte blastogenesis assay. The responsiveness of the 
cells to mitogens were compared to the T/B lymphocyte ratios 
from these animals. The effect of sera from AL and PL 
cattle on lymphocyte blastogenesis of BLV—negative control 
cattle was also evaluated to determine if suppressive or 
augmenting factors were present.
VI. B. MATERIALS AND METHODS 
VI. B. 1. Animals
A total of 9 cows of at least 3 years of age mere used 
in this study. The animals were examined clinically and 
hematologically for symptoms of bovine leukosis* and the BLV 
infection status was monitored by detection of serum 
antibodies to BLV structural antigens using the double 
immunodiffusion assay (33). Of the 9 animals* 3 were BLV- 
negative on repeated tests* 3 were AL and 3 were PL as 
determined by the critera of the International Committee of 
Bovine Leukosis (2). (For more details refer to Chapter 
VIII* Table VIII. 1.)
VI. B. 2. Isolation of Peripheral Blood Mononuclear 
Cel Is
Peripheral blood was collected by Jugular venipuncture 
into 20 ml vacutainer tubes containing 20 units/ml of
preservative-free heparin (Sigma Chemical Co.* U.S.A.). The 
heparinized blood was then diluted in an equal volume of 
calcium and magnesium free (CMF) Hanks buffer* pH 7.4.
Twenty milliliter aliquots were layered onto equal volumes 
of sodium diatrizoate/ficoll (Histopaque" 1D77* Sigma 
Chemical Co.* U.S.A.) in 50 cc conical centrifuge tubes 
(CDstar* U.S.A.). The gradients were centrifuged for 30 min 
at 1000 x g at room temperature* and the cells banded at the 
Histopaque"—plasma interface were collected and washed twice 
in CMF Hanks buffer at 50D x g for ID min at room 
temperature. Viability counts were done using 900 ul of 10% 
trypan blue mixed with 100 ul of cells* and the peripheral 
blood mononuclear cell (PBMC) concentration was adjusted to 
2 x 10* viable cells/ml in RPMI 1640 medium (GIBC0* 
Burlington* Ontario) supplemented with NaHCo3 and 
antibiotics (100 units/ml of penicillin and 100 ug/ml of 
streptomycin* 5 ug/ml gentamycin).
VI. B. 3. Complete Blood Counts
Blood was collected in tubes containing 
ethylenediaminetetraacetic acid as an anticoagulant. Total 
leukocyte counts were determined on an automatic cell 
counter and differential counts were performed.
VI. B. 4. Enumeration of T/B Lymphocyte Ratios
Aliquots of PBMC which were isolated for the lymphocyte 
blastogenesis assays were stained for B and T lymphocyte 
enumeration using the following procedure. To identify B 
lymphocytes* 3 x 10* PBMC were mixed with 10D ul (G.74mg/ml)
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of fluorescein—conjugated Ftab'J^. fragments of rabbit anti- 
bovine IgG, H & L chains specific <Cappel Labs,
Cochranvi1le, PA). To identify T lymphocytes, 3 x 10fc PBMC 
were mixed with 10 ul B26a (1 mg/ml, bovine pan T cell 
monoclonal antibody which recognizes the sheep RBC receptor 
on T lymphocytes) (courtesy of Dr. William Davis, Washington 
State University, Pullman* WA>. The PBMC were incubated at 
A C for 30 min in the dark, then washed twice in 1 ml 
aliquots of phosphate buffered saline (PBS) pH 7.4 with 
0.05% NaN3 (PBS NaN3 ) to prevent antibody capping. PBMC 
pretreated with B26a were stained with 100 ul (1 mg/ml) of 
fluorescein-conjugated goat anti-murine IgG, IgA, IgM 
mixture (goat anti-mouse-FITC) (Cappel Labs., Cochranvi1le, 
PA), incubated and washed as described above. The PBMC were 
then fixed in 0.551 formalin in PBS-NalM3. An aliquot of PBMC 
was also stained with goat anti—mouse FITC as a control.
The method used for the detection of fluorescence- 
positive celIs was fluorescence microscopy. Positive cells 
were enumerated by counting 200 cells at 1000 x 
magnification with the aid of a fluorescence microscope 
equipped for phase contrast and incident UV light 
illumination (Leitz, Germany). The T/B ratio was then 
determined by dividing the average of the percent T 
lymphocytes by the average of the percent B lymphocytes in 
the peripheral blood of each animal.
VI. B. 5. Serum Preparation
Twenty ml of blood was collected from each animal into
lOD
vacutainer tubes at sane tine blood was removed for 
blastogenesis assays. The blood was allowed to clot at room 
temperature for one hour, and centrifuged at 1000 x g for 15 
min. The harvested serum was filter sterilized by 
ultrafiltration with a 0.45 um disposable syringe filter 
(AcrodiscR, Gelman, U.S.A.). One half of the serum was heat 
inactivated at 56 C for 30 min* and the remaining serum was 
kept at 25 C until used. The sera (both heat inactivated 
and fresh) were then diluted in RPMI 1640 medium to a final 
concentration of 40% which was mixed in the lymphocyte 
blastogenesis test with an egual volume of cell suspension 
to yield 20% final concentration. Heat inactivated fetal 
calf serum (FCS) and heat inactivated sera from BLV-negative 
cows were diluted to 40% with RPMI 1640 medium and used as 
serum controls.
VI. B. 6. Preparation of Mitogens
Suboptimal and optimal concentrations of Con A* PHA, 
and PWM as determined by pre-testing on the PBMC of BLV- 
negative, clinically normal animals were prepared in RPMI 
1640 medium.
VI. B. 7. Lymphocyte Blastogenesis Assay
The lymphocyte blastogenesis assay was performed as 
previously described (143). Briefly, the test was conducted 
in flat-bottom, 96-well, tissue culture plates with 2 x 10= 
viable PBMC cells/well. Medium in the wells contained a 
final concentration'of 20% (v/v) of serum. Each animal's 
lymphocytes were tested with the following sera added: fresh
ioi
autologous sera, heat-inactivated autologous sera* heat- 
inactivated control BLV-negative sera* and FCS (Fig. VI.2.). 
The total well content was 0.2 ml* to which 1 of the 
following had been added (final concentrations): Con A* 5 
and 30 ug/ml; PHA* 2 and 5 ug/ml; and PWM* 0.05 and 0.2 
ug/ml. The lower concentrations represented the subDptimal* 
and the higher concentrations* the optimal doses of mitogens 
to stimulate lymphocytes from a majority of clinically 
normal cows. For each animal's cells* there were 6 control 
wells used with PBMC without addition of the mitogens* and 3 
wells for each mitogen concentration and the given serum 
addition. (Refer to Figure VI.1 for flow diagram.)
To test for the presence of blastogenesis augmenting or 
suppressive factors in the serum of BLV-infected animals* 
serum was obtained from 3 AL and 3 PL animals and 2 BLV- 
negative control animals at 2 intervals 30 days apart and 
processed as above then applied to lymphocytes of BLV- 
negative animals. Heat— inactivation was used to determine 
if possible augmenting or suppressive factors present in the 
serum were heat stable.
The PBMC were incubated at 37 C in 5Z CCL. for 3 days* 
labeled with [3HDthymidine (1 uCi/well)* and incubated for 
an additional A hours. The PBMC were harvested onto Skatron 
filter mats* using a multiple-well cell harvester (Skatron* 
Norway). After treating each sample with Concifluor” 
toluene scintillation cocktail (Fisher Scientific* U.S.A.)* 
the radioactivity or counts per minute (cpm) was determined
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using a scintillation counter (Packard TriCarb, Union 
Carbide* U.S.A.).
VI. B. 7.Statistical Evaluations
Statistical evaluations were performed on log 
transformed data using standard programs of the Prophet 
Computer System (U.S. Dept, of Health and Human Resources* 
Bethesda* HD.). To test the hypothesis of homogeneity of 
variance the Bartlett's test was used (14). A two-tailed T— 
test using unpooled variances was performed on all data 
(136* 14). The nearest P value was calculated. Data were 
considered significant at a level of P < 0.05.
VI. C. RESULTS
The results of blastogenesis assays were expressed as 
the log of the stimulation index (S.I. = cpm of mitogen- 
stimulated PBMC divided by cpm of unstimulated PBMC grown in 
the presence of the same serum) (Fig. VI. 3) and as the log 
of delta counts per minute (cpm of mitogen—stimulated PBMC 
minus cpm of unstimulated PBMC grown in the presence of the 
same serum ) (Fig. VI 4.). The responses of lymphocytes 
from the animals used in blastogenesis assays were 
determined using FCS as the serum source because of the 
variability encountered when autologus and homologus sera 
were used.
There were no significant differences noted between the 
responsiveness of PBMC from AL and BLV-negative animals when 
SI was used to measure the response to Con A* PHA* and PWM
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(Table VI. 1). The PBMC of PL animals appeared to have a 
significant decrease in the blastogenic response to Con A (p 
< 0.01), PHA (p < 0.01) and PWM (p < D.G2) when SI was used 
as a measure of the mitogenic response. It was also 
observed that the spontaneous blastogenesis (PBMC cultured 
with no mitogen) was significantly higher for the BLV- 
infected anixals when compared to that of BLV-negative 
animals (Table VI. 2).
When delta cpms were used as a measure of the mitogenic 
responsiveness of lymphocytes from AL and PL animals* it was 
found that there were no significant differences in the 
responses to any of the mitogens when compared to the 
mitogenic response of lymphocytes from BLV—negative animals 
(Table VI. 2).
T/B lymphocyte ratios from BLV-negative control* AL and 
PL animals are shown in Table VI. 3. The T/B ratios from PL 
animals were lower than those from either AL or BLV-negative
control animals. There were fewer T and more B lymphocytes
in the PBMC preparations used in the blastogenesis assay for 
these animals (B 10, Y 11* Y 13). There was an increase in
the T/B ratio of AL animals when compared to PL or BLV-
negative animals.. There were fewer B and more T lymphocytes 
in the PBMC preparations used in the assay. When lymphocyte 
responses to phytomitogens were compared to T/B ratios using 
linear regression analysis, it was found that there was no 
correlation between
The presence of possible suppressive or augmentative
IDA
factors for blastogenesis in the sera of BLV-infected 
animals was assessed by the addition of these sera to PBMC 
from BLV—negative control animals in the presence of 
mitogens. The data was expressed as corrected counts per 
minute (cpm of mitogen—stimulated BLV-negative PBMC in the 
presence of BLV-infected serum minus cpm of mitogen- 
stimulated BLV-negative PBMC in the presence of BLV-negative 
serum) (Figure VI. 5). The sera from AL and PL animals 
augmented the mitogenic response of lymphocytes to optimal 
concentrations of Con Ai PHA and PWM in comparison to the 
reponses observed BLV-negative control sera. No 
augmentation was observed in cultures without mitogen. The 
blastogenic response of the lymphocytes to all mitogens was 
greater in sera from PL animals than sera from AL. The 
blastogenesis augmenting factor was active on both T and B 
lymphocytes and was heat stable at 56 C for 30 min.
VI. D. DISCUSSION
The stimulatory effect of optimal concentrations of PHA* 
Con A and PWM on the PBMC from BLV-negative control animals 
could be demonstrated clearly in the experiments reported 
herein. The values obtained in lymphocyte blastogenesis 
studies with optimal concentrations of mitogens were used in 
this study to assess the blastogenic responsiveness of 
lymphocytes. The use of suboptimal concentrations ofi
mitogens gave no different information on the response of
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lymphocytes to various mitogens. These data are not 
presented.
When SI was used to measure the mitogenie 
responsiveness of lymphocytes from BLV—infected animals* 
there appeared to be a false assessment of the response due 
to the high spontaneous blastogenesis observed in the 
unstimulated PBMC cultures. SI was calculated by dividing 
the cpm obtained from mitogen—stimulated PBMC by the cpm of 
unstimulated PBMC. If spontaneous blastogenesis was high 
and the response to mitogens was within the normal range 
then the SI was low. Therefore* the PL animals which had 
high spontaneous blastogenesis had low SI.
The observations that lymphocytes from PL animals 
undergo high levels of spontaneous blastogenesis and have 
low SI are in agreement with previous reports (112*143).
This information led to the original conclusion that 
lymphocytes from PL animals have depressed responses to 
mitogenie stimulation. This does not appear to be a correct 
conclusion as discussed below. The observation that the 
lymphocytes of AL animals undergo high levels of spontaneous 
blastogenesis has not been previously reported.
When delta counts per minute were used to measure the 
mitogenie responsiveness of lymphocytes from AL and PL 
animals* no significant difference was noted when compared 
to the response observed for the lymphocytes of BLV-negative
animals. This suggested that the lymphocytes of BLV-
/
infected AL and PL animals are capable of normal mitogenie
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response to both T and £ lymphocyte mitogens.
It has been observed that there is an increase in the 
absolute number of T lymphocytes in the peripheral blood of 
AL animals (Chapter 111). It was shown in this study« that 
T/B ratios were higher in AL animals than either PL or BLV- 
negative animals. More lymphocytes with T lymphocyte 
markers were present in the PBMC preparations of AL animals 
used for the blastogenesis assays. This increase in T 
lymphocyte numbers did not appear to affect the overall 
response to optimal concentrations of the mitogens used in 
this study. It has been shown that the response of 
lymphocytes to Con A is a property of the T lymphocyte 
population but is dependent on accessory cells (monocytes) 
(B2*86). Therefore* even though T lymphocyte numbers were 
more numerous in the cultures from AL animals used for the 
mitogenie studies* the limiting factor may have been the 
concentration of monocytes in the culture.
It was also observed that as the T/B ratios decreased 
(PBMC of PL animals)* there was no significant increase or 
decrease in the ability of the cultured cells to respond to 
mitogens. Even though there were more B lymphocytes in the 
cultures of PL animals used in the blastogenesis assay* the 
response to PVNi was not elevated. Responsiveness to PWM is 
predominantly a property of B lymphocytes (111*112). The 
ability of B lymphocytes to respond to PWM is T lymphocyte
(T—helper) dependent (112*111). Even though there was an
/
increase in the number of lymphocytes with B lymphocyte
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markers in the cultures used for mitogenie studies* no 
increase in the response was observed because the 
concentration of T—helper cells might have been the limiting 
factor-
The increase of peripheral blood T lymphocytes in AL 
animals and Blymphocytes in PL animals mag be the result of 
antigen-induced expansion of T and B lgmphocgte clones* 
respectivelg. These cells mag also be responding to 
infection bg BLV (Chapter V* 91)- The high spontaneous 
blastogenesis as measured bg the synthesis of DNA indicates 
that cells in the cultures from AL and PL animals were 
undergoing high levels of mitosis. These stimulated cell 
populations might have been refractory to further mitogenie 
stimulation therefore* no increase in the response to 
mitogens was observed. It was concluded that the increase in 
the relative numbers of T and B lymphocytes in the cultures 
used for blastogenesis assays did not affect the response to 
selected phytomitogens. Therefore* the lymphocytes of AL 
and PL animals were considered as responsive to mitogenie 
stimulation as lymphocytes from BLV-negative* clinically 
normal animals
Sera from AL and PL animals contained a heat—stable 
blastogen'esis-augmenting factor(s). This factor enhanced 
the mitogenie response of lymphocytes from BLV-negative 
animals for Con A* PHA and PWM. No augmentation was
observed with BLV-negative control sera nor was
/
blastogenesis augmentation observed in the absence of
10B
mitogenie stimulation. Therefore* it was assumed that this 
factor was a comitogenic serum factor or one that works in 
the presence of mitogens or exhibits its activity on mitogen 
and /or antigen—activated cells. Sera from PL animals gave 
a higher degree of stimulation than did sera from AL 
animals.
Since the augmenting factor enhanced the blastogenic 
activity of all three phytomitogens* it was assumed that the 
effect was on both B and T lymphocytes. This factor was 
heat stable. No further characterization of the serum 
factor was attempted in this study.
Uhen HTLV—III— infected T lymphocytes are stimulated to 
divide by antigen activation* the viral genome is also 
activated (105). There is then production of the trans- 
activation of transcription <tat) viral gene product. This 
protein enhances the expression of not only the proviral 
genes but also the genes for interleukin—2 and its receptor 
(105). The infected cells are then further activated to 
divide. This tat enhancement of antigen—driven lymphocyte 
blastogenesis also appears to occur in the other HTLVs (I
and II) (105). BLV is closely related to HTLV I and II and
>has been found to contain a tat gene (128*131). The co­
rn i tog enic factor found iii the sera of BLV—infected animals 
may be the tat protein. The enhancement of mitosis was only 
apparent when PBMC of BLV-infected animals are cultured in 
the presence of mitogens and sera from BLV—infected animals. 
The mitogenie activation of lymphocytes appeared to be
10?
necessary before this protein bias able to enhance the 
blastogenic response. An increase in concentration of this 
factor in the sera of PL animals may be responsible for 
maintenance of the PL state.
The T and B lymphocytes of BLV-infected animals used in 
this study appeared to be responsive to the selected 
phytomitogens. Responsiveness to mitogens is used as an 
indicator of functional competence of lymphocytes 
(4,111*132). This study indicates that at least a portion 
of lymphocytes from AL and PL animals respond to mitogenie 
stimulation at least to a level comparable to that of 
lymphocytes from BLV-negative, clinically normal animals.
The blastogenenesis augmenting factor present in the sera of 
PL animals may be important in maintaining the PL stage of 
EBL.
The observation that BLV-infected animals have a 
blastogenesis augmenting factor present in their sera is 
important for the establishment of BLV-induced enzootic 
bovine leukosis as a model for HTLV I induced ATL. A T—cell 
lymphocytosis occurs in some cases of ATL (162). The tat 
protein appears to be responsible for the rapid 
proliferation of antigen-activated lymphocytes in this 
disease (105). If the tat protein of BLV is found to be 
responsible for the B-cell lymphocytosis observed in PL 
animals, BLV-induced persistent lymphocytosis in cattle may 
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Table VI. 1. Statistical Analysis of Lymphocyte Blastogenesis 
of Lymphocytes from Bovine Leukemia Virus 
Infected Cattle Using Stimulation Index*
**BLV
Status
Mitogen T Value Degrees of 
Freedom
P Value
BLV (-) Vs 
BLV (AL) Con A 1.391 16 N.S.-̂
PfiA 1.495 16 N.S.
EWM 0.631 16 N.S.
BLV (-) vs 
BLV (PL) Con A 2.654 16 0.01
FHA 2.257 16 0.01
PWM 3.985 16 0.02
*
Stimulation Index = cpns of mitogen treated cultures divided 
by cpns of cultures with no mitogen.
**
BLV Status indicates: BLV (-) = Cattle negative for BLV
antibodies. BLV(AL) = Cattle positive for BLV antibodies but 
have no clinical signs. BLV (PL) = Cattle positive for BLV 
antibodies and have persistent lymphocytosis.
+
Optimal Concentrations.
Not significant at the level of p = 0.05.
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Table VI. 2. Statistical Analysis of Lymphocyte Blastogenesis 
of Lymphocytes from Bovine Leukania Virus A
Infected Cattle Using Corrected Counts per Minute
**BLV
Status
■ + Mitogen T Value Degrees of 
Freedom
p Value
BLV (-) vs 
BLV (AL) None 2.015 16 0.05
Con A 1.629 16
I. I.N.S.
PHA 1.894 16 N.S.
PWM 1.858 16 N.S.
BLV (-) vs 
BLV (PL) None 2.677 0.02
Con A 0.3512 16 N.S.
PHA 0.3522 16 N.S.
PVM 0.1246 16 N.S.
Corrected counts per minute = cpns of mitogen treated cultures 
minus cpns of cultures with no mitogen treatment.
**
BLV Status indicates: BLV (-) = Cattle negative for BLV
antibodies. BLV(AL) = Cattle positive for BLV antibodies 
but have no clinical signs, BLV (PL) = Cattle positive 




Not significant at the level of p = 0.05.
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R 52 mm 1.9
R 54 - 2.0
Y 73 2.0
Y 32 AL 3.2
Y 74 AL 5.1
Y 75 AL 3.3
B 10 PL 0.5
Y 11 PL 0.8
Y 13 PL 0.7
T/B ratio = %T lymphocytes in peripheral blood
divided by the % B lymphocytes in the peripheral 
blood.
CHAPTER VIis SUMMARY
The aim of the investigations reported herein was to 
obtain a better understanding of the numbers and function of 
bovine T lymphocytes in bovine leukemia virus (BLV) infected 
cattle in the aleukemic (AL) and persistent lymphocytotic 
(PL) stages of enzootic bovine leukosis.
Highly specific monoclonal antibodies that distinguish 
bovine T and B lymphocytes and flow microfluorimetry (FACS 
analysis) were used to determine the absolute number of B 
and T lymphocytes in the peripheral blood of ELV-infected 
cattle. The peripheral blood lymphocyte populations from A 
AL and 4 PL cattle appeared to be increased when compared to 
that of 4 BLV negative control animals. The increase in the 
lymphocyte population in the AL animals was due to an 
increase in T lymphocytes but not B lymphocytes* whereas* in 
the PL animals the increase appeared to be due to an 
increase in both T and B lymphocyte populations. This 
information indicates that there is an alteration in the 
lymphocyte populations of BLV-infected cattle.
The PL animals showed a significantly higher number of 
surface immunoglobulin positive cells (slg"’') than did the AL 
animals. The majority of these cells had IgM on their cell 
surfaces* which is typical for virgin (res'ting)* 
intermediate or memory B lymphocytes. Therefore* it appears 
that these cells have been induced to proliferate but not to 
differentiate into antibody secreting (plasma)
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cells because plasma cells typically do not have surface 
bound IgM as do intermediate mature (activated) B 
lymphocytes and are rarely found in the peripheral blood. 
This observation indicates that the increase in the numbers 
of lymphocytes in the peripheral blood of PL animals is not 
totally an antigen driven event. It is possible that the 
uncontrolled lymphocytosis is at least in part due to the 
activity of a trans activational transcriptional protein 
(tat protein) (a product of the BLV genome). It was shown 
in this study that there is a comitogenic blastogenesis 
augmenting factor in the sera of all AL and PL animals 
tested. This factor may be responsible for the further 
proliteration of antigen—activated lymphocytes. It has been 
observed that antigen-activated HTLV III virus infected 
cells are further induced to proliferate as a result of the 
tat protein.
PL animal 632 had an elevated lymphocyte count (72 x 
lCP/mm3 of whole blood) and contained a subpopulation of 
lymphocytes that appeared to stain for markers of both 
bovine B and T lymphocytes. This suggested that these cells 
mere immature. It has been observed that animals with LS 
contain immature lymphocytes circulating in the peripheral 
blood. Perhaps this is the BLV—infected cell population.
We were unable to guantitate the number of T lymphocytes in 
this animal using cell surface markers. The lymphocytes of 
this animal stained much more intensely with the anti-bovine 
Igli monoclonal antibody than lymphocytes from the other PL
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animals tested. This suggests that there is modulation of 
the expression of this immunoglobulin marker in animal 632. 
Perhaps the gene that codes for cell surface bound IgM is 
enhanced in its expression in PL animals as a response of 
the tat protein effect on lymphocytes in the peripheral 
blood.
Bovine T lymphocytes were purified from the peripheral 
blood of BLV-infected* AL cattle using immuno-affinity 
depletion <"panning") with anti-bovine immunoglobulin-coated 
flasks. Large yields of highly purified T lymphocyte 
preparations (95-100X T lymphocytes and 0-35C contamination 
with B lymphocytes) were obtained from BLV-negative and AL* 
but not PL animals by the use of this technique. This 
purification technique was easy to perform* required minimal 
amounts of reagents and gave higher yields of purified T 
lymphocytes than any other currently available purification
technique. It was then possible to assess the presence of
BLV provirus in highly purified T lymphocyte populations of 
AL animals.
A 7.5 kilobase fragment of the original BLV—provirus 
probe (EcoRl fragment of the FLK-BLV DNA ligated into PUC-S 
vector plasmid) was purified by Sac 1 restriction enzyme 
digestion* agarDse gel electrophoresis and subsequent 
fragment electroelution. The presence of BLV provirus was 
then demonstrated in the DNA of the peripheral blood
mononuclear cells of all AL animals tested and 3 of the 4
purified T lymphocyte preparations using DNA hybridization
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techniques with the highly specific radiolabelled (3=P) BLV- 
DNA probe. This study documents the first attempt to assess 
the presence of the BLV provirus in highly purified 
peripheral blood T lymphocytes from BLV— infected* AL cattle. 
These experiments shouted that bovine T lymphocytes are 
possible targets of BLV infection. The significance of this 
finding is that infection of T lymphocytes or a specific 
subpopulation of T lymphocytes may lead to modulation of 
this cell population and may facilitate the progression of 
the disease to the PL and ultimately the tumor state.
This study also confirmed that the B lymphocyte is the 
major target of BLV infection. As these cells were depleted 
from the PBMC by "panning", the hybridization signal that 
was obtained from purified DNA of the "panned" cells was 
much less dense than the signal obtained from the PBMC 
preparation.
The lymphocyte blastogenesis assay was used as an 
indicator of the functional ability of lymphocytes of AL and 
PL animals to respond to mitogenie stimuli. It appeared, 
that the responsiveness of lymphocytes from AL and PL 
animals to Con A, PHA, and PWM mitogens was comparable to 
that of lymphocytes from BLV-negative animals when delta 
cpms were used as measurement of mitogenic—induced 
blastogenesis. This indicated that the infection of some 
cells of the lymphocyte population does not appear to alter 
the overall response of the lymphocytes to mitogenie 
stimuli.
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High levels of spontaneous blastogenesis in the absence 
of mitogenie stimulation was observed for lymphocyte 
preparations of both AL and PL animals. The reason for this 
proliferation of lymphocytes is unclear. Sera from AL and 
PL animals was found to contain a blastogenesis—augmenting 
factor(s) when added to lymphocytes from BLV-negative 
control animals in the presence of Con A* PHA and PWM. 
Therefore* it appeared that the effect of augmentation was 
on B and T lymphocytes. Perhaps this serum factor is the 
tat protein. The PL animals appeared to have more of this 
factor or a more active form of this factor in their sera 
than the AL animals. The PL animals also had higher levels 
of spontaneous blastogenesis and higher rates of lymphocyte 
proliferation in vivo as Judged by peripheral blood 
lymphocytes counts. The presence of the blastogenesis- 
augmenting factor(s) in tne serum of BLV—infected animals 
may facilitate the transition from AL to PL phase of EBL and 
/or is at least partly responsible for maintenance of the PL 
phase of EBL.
CHAPTER VIIis APPENDIX
The animals used in this project mere cows of various 
breeds between the ages of 3 and 5 years old (Table VIII. 
i>. They were purchased from sale barns in southern 
Louisiana and maintained at the Veterinary Medicine Farm* 
Lousiana State University Agricultural Center* Louisiana 
State University* School of Veterinary Medicine* Baton 
Rouge* Louisiana for at least 3 months before being used in 
the project. The animals were neither pregnant* nor 
lactating. They were judged healthy on physical exam by the 
staff veterinarian. All BLV positive animals were naturally 
infected* therefore* it was not known when infection 
originally occurred. It was not known when persistent 
lymphocytosis developed.
Peripheral blood was collected from all test animals at 
monthly intervals prior to and during the project. Serum 
was harvested* and the agar gel immunodiffusion test (AG2D) 
was performed for the detection of antibodies to BLV 
antigens. Total WBC and differiential counts were performed 
at monthly intervals to establish the BLV status (AL or PL). 
Animals with detectable serum antibodies to BLV antigens but 
no clinical signs of disease were considered to be aleukemic 
animals (AL). Animals with detectable serum antibodies to 
BLV antigens and a persistent elevation of peripheral blood 
lymphocytes (> 7.5 x lCPcelIs/mm3 whole blood over a three 
month period) were considered persistent lymphocytotic
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art i male <PL) (2). Animals with no detectable antibodies to 
BLV antigens on repeated testing were BLV-negative animals. 
These BLV negative animals were used as control animals in 
all studies. All animals were also palpated for the 
presence of tumors. No tumors were observed in any of the 
test animals.
Animals were screened for Brucellosis and Anaplasmosis 
and found negative. They were also vaccinated for bovine 
diarrhea virus* infectious rhinotracheitis virus and 
parainfluenza virus type III by the Louisiana State 
University School of Veterinary Medicine clinical staff.
The presence of antibodies to bovine lymphotrophic 
retroviruses* bovine syncytial virus (BSV) and bovine visna- 
like virus (BVV) was also evaluated. Antibodies to these 
viruses were detected by the use of indirect
immunofluoresence test assays utilizing bovine fetal spleen 
cells infected with either BSV or BVV (Table VIII. 1).
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Table VIII. 1. Assessment of Viral Infection in Animals 





BLV+ BSV** b v vh +
R 52 Holstein + +
R 54 Holstein - -
R 56 Holstein , - * -
Y 73 Jersey — — —
Y 12 Holstein + (AL) _
Y 32 Holstein + (AL) + -
Y 74 Jersey + (AL) - +
Y 75 Jersey + (AL) — —
B 10 Hereford + (PL) +
Y 11 Holstein + (PL) + —
Y 13 Holstein + (PL) — +
Y 632 Holstein + (PL) +
-fBLV antibodies determined by the use of agar gel 
iimtunodiffusion. BLV status determined by clinical 
signs.
BLV (-) - Animals with no detectable BLV antibodies 
BLV (+)AL - Animals with detectable antibodies to 
BLV antigens but no clinical signs of disease 
BLV (-f)PL - Animals with detectable BLV antibodies 
and exhibit persitent lymphocytosis.
++BSV - Bovine syncytial, virus
I | |BVV - Bovine visna-like virus
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